Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3000242	li-tau	pg/ml (ng/l)	1897	1940	0.31%
3000242	li-tau	— (—)	744	760	100.00%	Distribution not available
3000242	li-tau	pg/ml_____ (ng/l)	45	46	0.00%
3000242	li-tau	ng/l (ng/l)	16	16	0.00%	Distribution not available
3000242	li-tauproteiini,likvor	pg/ml (ng/l)	13	13	0.00%	Distribution not available
3000242	li-tau	pg/mL (ng/l)	10	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any dementia, excluding more controls

1153

424

19.81

307.65

1.0

395.47

307.95

ng/l

3.04

901

252

Alzheimer’s disease (Late onset)

568

367

13.30

307.65

1.0

428.47

274.77

ng/l

17.50

428

214

Implicit Sepsis, including avohilmo

1389

1141

8.91

307.65

1.0

286.25

401.81

ng/l

2.33

1165

707

Any dementia

1161

546

15.51

307.65

1.0

396.54

287.34

ng/l

6.09

906

333

Alzheimer’s disease (Late onset), excluding more controls

542

130.10

307.65

1.0

1.1

418.24

474.08

ng/l

0.11

413

Condition for Implicit Sepsis (Organ dysfunction codes)

1548

929

11.85

307.65

1.0

293.66

414.31

ng/l

1.61

1298

530

Unspecific neurodegenerative disorder

1259

517

17.62

307.65

1.0

385.17

306.71

ng/l

1.69

940

326

Normal-pressure hydrocephalus

360

108

40.91

307.65

1.1

1.0

247.41

346.87

ng/l

2.04

122

Dementia in Alzheimer disease

372

157

20.57

307.65

1.0

415.07

238.52

ng/l

12.75

243

Implicit Sepsis

1151

1358

6.37

307.65

1.0

288.53

377.64

ng/l

2.17

958

894

Alzheimer’s disease, strict definition

827

400

17.70

307.65

1.0

417.72

272.34

ng/l

21.54

648

240

Dementia

1331

426

22.61

307.65

1.0

382.21

272.25

ng/l

5.43

997

271

Dementia, including avohilmo

1399

512

19.71

307.65

1.0

371.38

268.73

ng/l

6.24

1044

328

Symptoms and signs involving cognition, perception, emotional state and behaviour

1700

811

14.36

307.65

1.0

323.23

337.90

ng/l

0.26

1398

449

Use of rivastigmine

390

388

10.52

307.65

1.0

367.36

331.44

ng/l

1.22

297

240

Use of other anti-dementia drugs

634

527

10.09

307.65

1.0

415.12

322.83

ng/l

6.52

467

332

Alzheimer’s disease (Early onset)

294

57.56

307.65

1.0

410.84

212.92

ng/l

14.09

244

Other mental disorders due to brain damage and dysfunction and to physical disease

458

147

33.97

307.65

1.0

304.25

222.41

ng/l

5.66

334

103

N06DA Anticholinesterases

1059

556

15.53

307.65

1.0

395.79

288.74

ng/l

13.39

789

356

Psychiatric diseases

903

503

9.10

307.65

1.0

331.91

342.13

ng/l

0.05

669

351

Organic, including symptomatic, mental disorders

1549

535

21.51

307.65

1.0

363.96

257.98

ng/l

7.18

1155

349

Alzheimer disease, excluding more controls

880

164.64

307.65

1.0

1.1

399.80

430.97

ng/l

0.07

685

Degenerative diseases of the nervous system

1162

534

16.58

307.65

1.0

380.35

286.12

ng/l

10.98

909

329

Other symptoms and signs involving cognitive functions and awareness

1643

607

25.51

307.65

1.0

329.35

353.49

ng/l

0.41

1397

332

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1600

753

14.71

307.65

1.0

300.03

424.98

ng/l

1.22

1307

425

Alzheimer disease, including avohilmo

1104

521

15.48

307.65

1.0

398.68

290.86

ng/l

7.35

816

330

Other degenerative diseases of the nervous system

1113

176

49.40

307.65

1.0

373.08

370.75

ng/l

0.01

882

126

Use of donepezil

624

456

13.83

307.65

1.0

425.93

299.80

ng/l

12.88

468

287

Use of anticholinesterases

1059

556

15.53

307.65

1.0

395.79

288.74

ng/l

13.39

789

356

Use of memantine

634

527

10.09

307.65

1.0

415.12

322.83

ng/l

6.52

467

332

Any mental disorder

1057

823

6.51

307.65

1.0

334.52

326.16

ng/l

0.06

800

548

Alzheimer disease

955

503

14.30

307.65

1.0

406.36

287.37

ng/l

15.19

732

308

Hydrocephalus

388

165

26.58

307.65

1.1

1.0

248.45

342.85

ng/l

2.39

135

116

Alzheimer’s disease (Early onset), excluding more controls

294

321.58

307.65

1.0

410.84

242.90

ng/l

—

244

Depression or dysthymia

484

276

9.67

294.69

1.0

274.24

424.79

ng/l

0.55

345

190

Mood disorders, excluding more controls

695

809

5.09

265.36

1.0

250.02

326.80

ng/l

0.92

517

544

Intracranial trauma

389

311

8.52

247.66

1.0

387.66

314.74

ng/l

0.33

272

230

Implicit viral Sepsis, including avohilmo

396

621

6.50

239.47

1.0

292.89

363.77

ng/l

2.46

324

391

Unspecified dementia

198

20.15

239.25

1.0

326.46

234.76

ng/l

3.34

160

Circumscribed brain atrophy

141

43.14

230.96

1.0

279.11

206.81

ng/l

2.45

120

Memory loss

191

116

17.28

229.53

1.0

304.05

218.86

ng/l

3.93

153

Other neurological diseases

762

1641

3.65

214.57

1.1

1.0

364.41

332.81

ng/l

0.21

442

1285

Neurological diseases

482

372

6.55

213.83

1.0

319.11

305.32

ng/l

0.20

348

275

Dizziness and giddiness

490

774

4.96

205.14

1.0

303.77

343.71

ng/l

1.29

339

428

Concussion

309

310

7.79

197.86

1.0

401.59

314.74

ng/l

0.32

222

230

Parkinson's disease, excluding more controls

130

33.83

191.58

1.0

1.1

259.60

421.55

ng/l

0.52

Symptoms and signs involving the nervous and musculoskeletal systems

603

1645

3.71

187.81

1.0

277.83

353.50

ng/l

2.29

416

1212

Implicit bacterial Sepsis, including avohilmo

482

939

4.33

175.07

1.0

273.36

347.82

ng/l

6.20

389

597

Recurrent or chronic depression

241

177

9.52

168.26

1.0

1.1

246.37

438.52

ng/l

0.46

171

128

Parkinson's disease, strict definition, excluding more controls

115

31.19

167.32

1.1

256.01

424.73

ng/l

0.53

Delirium, not induced by alcohol and other psychoactive substances

165

138

12.24

164.46

1.0

419.36

224.13

ng/l

1.59

121

Other and unspecified degenerative diseases of nervous system

114

24.84

158.18

1.1

282.70

233.11

ng/l

0.85

Undefined dementia

198

221

8.50

146.34

1.0

326.46

324.62

ng/l

0.03

160

130

Viral Sepsis

256

434

6.02

143.84

1.1

1.0

289.07

354.06

ng/l

1.55

203

272

Other antidepressants

735

1207

3.13

143.56

1.0

281.55

380.59

ng/l

2.54

521

898

Implicit viral Sepsis

255

432

6.02

143.38

1.1

1.0

289.07

354.04

ng/l

1.55

203

271

Implicit bacterial Sepsis

414

893

4.03

138.44

1.0

281.03

350.46

ng/l

4.88

333

574

Anxiety disorders, excluding more controls

456

741

3.95

135.30

1.0

254.45

317.91

ng/l

0.64

362

503

Use of galantamine

167

203

8.59

128.06

1.0

393.36

319.01

ng/l

1.98

125

122

Alzheimer’s disease (Atypical or mixed)

151

161

9.50

125.74

1.0

358.13

267.85

ng/l

2.64

100

Bacterial Sepsis

418

955

3.66

121.19

1.0

281.87

343.51

ng/l

4.23

336

613

Schizophrenia or delusion, excluding more controls

192

315

6.08

109.37

1.0

271.95

249.50

ng/l

0.63

156

208

Other symptoms and signs involving the nervous and musculoskeletal systems

383

1113

3.48

108.76

1.0

273.52

322.77

ng/l

3.54

270

819

Abnormalities of gait and mobility

196

342

5.91

107.35

1.1

1.0

265.32

346.57

ng/l

1.15

122

233

Selective serotonin reuptake inhibitors

649

1207

2.81

107.19

1.0

289.49

380.59

ng/l

2.18

464

898

Traumatic subdural haemorrhage

111

100

10.53

97.45

1.0

302.14

299.40

ng/l

0.03

Vascular dementia

107

102

10.32

93.84

1.0

322.10

247.22

ng/l

1.95

Mood [affective] disorders

704

1895

2.39

90.62

1.0

249.87

361.55

ng/l

6.35

524

1396

Mood disorders

704

1898

2.38

89.93

1.0

249.25

361.66

ng/l

6.45

523

1398

Dementia in other diseases classified elsewhere

14.34

87.31

1.0

417.56

212.95

ng/l

0.76

Substance abuse, excluding more controls

283

654

3.64

82.28

1.0

284.21

328.11

ng/l

0.33

216

448

Depression

644

1827

2.37

82.17

1.0

254.46

358.60

ng/l

5.40

473

1354

Malaise and fatigue

419

1158

2.87

81.53

1.0

298.62

383.19

ng/l

1.65

308

838

Medical observation and evaluation for suspected diseases and conditions

406

690

3.02

75.66

1.0

309.54

338.13

ng/l

0.88

262

549

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

152

104

7.37

74.12

1.0

267.42

336.89

ng/l

1.58

109

Epilepsy

254

736

3.48

72.25

1.0

338.30

331.52

ng/l

0.05

201

536

Extrapyramidal and movement disorders

342

1213

2.85

69.50

1.0

259.69

340.96

ng/l

8.54

246

857

Nonorganic sleeping disorders, excluding more controls

111

176

6.36

66.71

1.0

235.73

245.56

ng/l

0.20

119

Benzodiazepine use

646

2042

2.14

65.65

1.0

287.15

346.54

ng/l

2.18

485

1481

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

125

227

5.47

64.14

1.0

245.52

240.71

ng/l

0.10

163

Other and unspecified hydrocephalus

14.38

60.25

1.1

1.0

231.42

320.50

ng/l

1.29

Injuries to the head

677

1971

2.05

59.12

1.0

349.27

328.50

ng/l

0.16

496

1447

Neurological diseases, wide definition

111

8.12

57.98

1.0

279.45

266.38

ng/l

0.13

Postprocedural disorders of nervous system

8.05

57.57

1.0

337.31

295.22

ng/l

0.51

Vascular dementia (subcortical)

13.24

57.37

1.1

1.0

346.91

245.85

ng/l

1.70

General examination and investigation of persons without complaint and reported diagnosis

358

690

2.71

55.70

1.0

271.52

338.13

ng/l

3.97

250

549

Personality disorders, excluding more controls

108

216

5.02

50.59

1.0

210.55

238.69

ng/l

1.02

153

Convulsions, not elsewhere classified

178

514

3.45

50.23

1.0

283.47

332.49

ng/l

1.67

137

378

Use of levodopa decarboxylase inhibitor

156

442

3.59

46.60

1.0

263.79

326.65

ng/l

2.32

113

299

Intracranial injury

372

1553

2.24

45.51

1.0

394.13

325.66

ng/l

0.29

253

1116

Focal epilepsy

176

553

3.22

44.48

1.0

359.11

311.65

ng/l

0.31

136

387

Syncope and collapse

308

1073

2.41

43.44

1.0

283.50

358.12

ng/l

3.60

215

770

Bipolar affective disorders

124

318

3.94

42.68

1.0

222.27

339.28

ng/l

6.80

103

246

Focal epilepsy, mode (most common among epilepsy diagnosis)

159

488

3.30

41.82

1.0

373.13

310.65

ng/l

0.38

122

341

Unspecified mental disorder

250

999

2.52

40.28

1.0

238.55

315.54

ng/l

6.25

197

738

Depression medications

126

141

4.51

40.05

1.0

256.77

357.34

ng/l

2.78

110

Kela-code for severe mental illness

230

892

2.60

39.49

1.0

237.16

317.43

ng/l

5.93

179

663

Focal epilepsy, strict definition

163

527

3.13

39.35

1.0

367.57

312.19

ng/l

0.34

126

370

General symptoms and signs

549

1450

1.90

37.82

1.0

280.78

364.02

ng/l

2.42

402

1076

Other extrapyramidal and movement disorders in other diseases

197

724

2.75

37.75

1.0

274.53

335.92

ng/l

3.72

143

521

Implicit fungal Sepsis, including avohilmo

149

5.13

35.80

1.1

1.0

273.93

343.67

ng/l

1.69

Anxiety (asthma-related co-morbidities)

301

1024

2.24

35.50

1.0

245.11

360.85

ng/l

2.83

238

773

Other degenerative diseases of the basal ganglia

8.21

34.41

1.0

217.87

336.18

ng/l

2.29

Other symptoms and signs involving general sensations and perceptions

10.47

34.30

1.0

302.39

249.50

ng/l

0.69

Other and unspecified nonorganic psychotic disorders

123

369

3.36

33.64

1.0

263.56

308.05

ng/l

1.39

100

269

Other special examinations and investigations of persons without complaint or reported diagnosis

308

690

2.27

33.58

1.0

319.88

338.13

ng/l

0.43

218

549

Schizophrenia or delusion

192

761

2.54

31.65

1.0

271.95

313.03

ng/l

1.43

156

565

Schizophrenia, schizotypal and delusional disorders

193

767

2.53

31.64

1.0

271.95

312.33

ng/l

1.39

156

567

Non-selective monoamine reuptake inhibitors

211

840

2.42

31.24

1.0

260.74

403.19

ng/l

2.64

151

632

Infections, IBD-co-morbidities

6.33

31.12

1.1

1.0

280.53

272.02

ng/l

0.08

Secondary parkinsonism, excluding more controls

43.63

31.05

1.1

1.0

252.87

226.22

ng/l

—

Persons encountering health services for examination and investigation

302

690

2.20

30.72

1.0

306.11

338.13

ng/l

0.94

209

549

Parkinson's disease, including avohilmo

147

525

2.84

29.93

1.0

270.09

321.96

ng/l

1.68

100

362

Constipation

523

2040

1.74

29.37

1.0

291.83

347.97

ng/l

1.89

386

1487

Other anxiety disorders

226

840

2.30

29.06

1.0

259.02

313.45

ng/l

2.73

177

632

Progressive vascular leukoencephalopathy

5.87

28.61

1.0

237.77

314.38

ng/l

1.77

Episodal and paroxysmal disorders

518

1496

1.76

28.29

1.0

297.23

339.92

ng/l

2.49

373

1085

Cerebrovascular diseases

476

1878

1.77

28.06

1.0

304.88

346.73

ng/l

1.08

339

1364

Fall on same level

572

1806

1.69

27.55

1.0

302.15

343.22

ng/l

1.08

418

1345

Other disorders of urethra and urinary system

392

1472

1.86

27.45

1.0

296.51

359.85

ng/l

1.52

286

1048

Communicating hydrocephalus

8.20

27.45

1.2

1.0

277.33

301.07

ng/l

0.13

Examination and observation for other reasons

264

690

2.17

26.78

1.0

282.50

338.13

ng/l

2.45

181

549

Headache

326

1326

1.91

25.21

1.0

274.25

369.07

ng/l

2.55

229

984

Covid-19 confirmed case

228

1076

2.13

25.08

1.1

1.0

291.37

332.87

ng/l

1.93

169

755

Hypothyroidism (congenital or acquired)

140

3.73

24.86

1.0

285.48

358.86

ng/l

1.25

109

Hypothyroidism and >3 levothyroxin purchases

140

3.66

23.70

1.0

290.94

358.86

ng/l

1.11

109

Hypothyroidism, levothyroxine purchases

140

3.66

23.70

1.0

290.94

358.86

ng/l

1.11

109

All anxiety disorders

301

1224

1.91

23.67

1.0

245.11

341.39

ng/l

2.66

238

911

Disorders of thyroid, IBD co-morbidities

5.43

23.65

1.0

262.63

268.74

ng/l

0.05

Open wound of head

306

1534

1.88

23.58

1.0

292.14

325.76

ng/l

1.45

228

1110

Anxiety disorders

459

1870

1.69

23.25

1.0

254.27

350.38

ng/l

4.62

364

1366

Alcohol abuse, main dg, excluding more controls

168

3.95

23.13

1.0

241.95

236.43

ng/l

0.09

116

Parkinson's disease

130

504

2.61

22.68

1.0

259.60

321.07

ng/l

2.16

345

STROKE

363

1370

1.79

22.51

1.0

287.73

359.31

ng/l

1.80

274

1021

Provisional assignment of new diseases of uncertain etiology

285

1502

1.89

22.49

1.1

1.0

284.23

354.04

ng/l

1.82

214

1061

Codes for special purposes

285

1503

1.89

22.43

1.1

1.0

284.23

353.92

ng/l

1.81

214

1062

Neurotic, stress-related and somatoform disorders

451

1859

1.68

22.26

1.0

254.05

349.82

ng/l

4.57

356

1361

severe traumatic brain injury, does not include concussion

156

674

2.33

21.50

1.0

294.16

315.84

ng/l

0.40

468

Metabolic disorders

491

1812

1.63

21.21

1.0

342.82

336.02

ng/l

0.03

374

1302

Focal brain injury

6.66

20.84

1.0

304.25

263.56

ng/l

0.26

Abnormal findings on diagnostic imaging of central nervous system

124

4.27

20.03

1.1

1.0

266.97

287.54

ng/l

0.16

Pure hypercholesterolaemia

448

1751

1.63

19.62

1.0

271.53

339.56

ng/l

6.06

351

1254

Abnormal involuntary movements

335

2.83

19.37

1.1

1.0

281.06

331.43

ng/l

0.91

239

Secondary parkinsonism+Parkinsonism in other disease

5.28

19.20

1.1

1.0

249.72

327.88

ng/l

0.92

Monoamine oxidase A inhibitors

207

3.36

19.09

1.0

316.32

355.42

ng/l

0.45

157

Parkinson's disease, strict definition

115

458

2.54

19.07

1.1

1.0

256.01

325.07

ng/l

2.25

309

Generalized anxiety disorder

213

3.30

18.85

1.0

253.96

314.03

ng/l

1.56

155

Care involving use of rehabilitation procedures

358

1926

1.68

18.67

1.0

367.94

320.12

ng/l

0.23

305

1383

Anaemias

139

3.42

18.56

1.0

302.24

358.86

ng/l

0.83

109

Persons encountering health services for specific procedures and health care

519

1973

1.56

18.52

1.0

358.36

317.72

ng/l

0.27

411

1417

Poisoning by medicine

110

437

2.53

18.29

1.0

249.81

318.90

ng/l

3.15

329

Other intervertebral disc disorders

408

1485

1.64

18.25

1.0

275.58

366.30

ng/l

2.88

297

1113

Disorders of lipoprotein metabolism and other lipidaemias

463

1780

1.59

18.05

1.0

279.26

337.98

ng/l

4.47

359

1279

Poisoning by drugs, medicaments and biological substances

118

493

2.41

17.62

1.0

249.46

316.72

ng/l

3.20

366

Other disorders of ear

490

2051

1.55

17.43

1.0

395.69

310.71

ng/l

0.59

351

1518

Secondary parkinsonism

4.95

17.41

1.1

1.0

252.87

323.29

ng/l

0.80

Other dorsopathies, not elsewhere classified

454

1487

1.59

17.31

1.0

283.69

366.11

ng/l

2.41

314

1114

Lower back pain or/and sciatica

528

2166

1.52

17.11

1.0

270.48

345.87

ng/l

3.55

361

1609

Low back pain

363

1487

1.65

17.08

1.0

276.33

366.11

ng/l

2.75

258

1114

Nonorganic sleeping disorders

111

459

2.43

16.98

1.0

235.73

311.41

ng/l

3.95

336

Superficial injury of head

131

589

2.23

16.50

1.0

305.44

335.26

ng/l

0.51

102

417

Dorsalgia

440

1487

1.57

16.11

1.0

275.67

366.11

ng/l

2.89

305

1114

Schizoaffective disorder

161

3.46

15.89

1.0

207.38

291.09

ng/l

2.99

113

Speech disturbances, not elsewhere classified

259

2.89

15.88

1.1

1.0

261.71

295.37

ng/l

0.57

169

Cerebrovascular diseases (FINNGEN)

197

718

1.93

15.79

1.0

289.44

338.68

ng/l

1.66

155

554

Manic episode

5.82

15.43

1.0

210.05

353.49

ng/l

1.82

Sequelae of cerebrovascular disease

215

1003

1.84

15.43

1.0

325.14

343.90

ng/l

0.35

161

703

Other diseases of urinary system

473

1753

1.52

15.08

1.0

306.14

340.68

ng/l

0.68

361

1268

Fever of other and unknown origin

259

1304

1.72

15.06

1.0

292.72

370.39

ng/l

1.64

179

952

Cerebral cysts

4.24

15.05

1.0

1122.22

317.20

ng/l

0.49

Motor neuron disease ALS

32.37

14.85

1.1

1.0

284.21

243.33

ng/l

—

Motor neuron disease (with DMD)

32.34

14.85

1.1

1.0

284.21

243.33

ng/l

—

Non-invasive ventilation

128

509

2.18

14.85

1.1

1.0

280.62

437.89

ng/l

1.47

118

375

Conductive and sensorineural hearing loss

444

1943

1.52

14.78

1.0

417.18

314.12

ng/l

0.66

315

1429

Follow-up examination after treatment for conditions other than malignant neoplasms

175

593

1.97

14.76

1.0

509.29

346.45

ng/l

0.38

132

475

Other reaction to severe stress, and adjustment disorders

153

767

2.00

14.56

1.0

255.14

364.18

ng/l

1.65

124

581

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

125

584

2.15

14.42

1.0

245.52

308.71

ng/l

3.05

439

Sensorineural hearing loss

430

1893

1.52

14.23

1.0

422.07

315.76

ng/l

0.66

304

1384

Lumbar disc prolapse

320

1469

1.62

14.22

1.0

288.83

366.02

ng/l

2.00

230

1106

Sleep disorders (combined)

504

1780

1.48

14.16

1.0

353.82

344.21

ng/l

0.05

375

1276

Other encephalitis

5.03

14.10

1.0

380.44

282.32

ng/l

0.64

Encephalitis

5.02

14.10

1.0

380.44

275.67

ng/l

0.70

306

1652

1.62

13.90

1.0

288.00

312.36

ng/l

0.92

232

1214

Other headache syndromes

192

1053

1.82

13.84

1.0

463.38

329.26

ng/l

0.30

131

768

Falls/tendency to fall

458

1528

1.50

13.73

1.0

301.46

326.83

ng/l

0.95

339

1135

Viral infections of the central nervous system

153

3.30

13.53

1.0

909.09

289.17

ng/l

1.20

109

Sequelae of injuries of head

129

3.54

13.50

1.0

285.43

266.92

ng/l

0.18

Symptoms and signs involving speech and voice

187

1035

1.82

13.29

1.0

347.76

329.92

ng/l

0.11

156

730

Spondylopathies

384

1479

1.54

13.26

1.0

275.96

367.00

ng/l

2.90

254

1109

292

1629

1.61

13.01

1.0

290.14

312.45

ng/l

0.78

223

1195

Sciatica+with lumbago

263

1421

1.64

12.88

1.0

259.92

368.76

ng/l

3.52

171

1075

Viral infections of the central nervous system, including avohilmo

163

3.16

12.88

1.0

898.17

294.59

ng/l

1.21

114

Shoulder lesions

392

1552

1.52

12.75

1.0

304.70

353.85

ng/l

1.08

288

1137

Disorders of adult personality and behaviour

117

560

2.10

12.74

1.0

210.76

311.77

ng/l

8.69

429

Mental and behavioural disorders due to alcohol

259

1509

1.64

12.72

1.0

295.72

311.48

ng/l

0.44

198

1112

Viral encephalitis, not elsewhere classified/unspecified

5.59

12.65

1.0

328.94

281.50

ng/l

0.25

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

5.59

12.65

1.0

328.94

281.50

ng/l

0.25

Pain in throat and chest

384

1497

1.52

12.64

1.0

368.69

332.78

ng/l

0.16

289

1082

Mental and behavioural disorders due to psychoactive substance use

294

1700

1.59

12.61

1.0

287.91

330.23

ng/l

0.99

226

1256

Factors influencing health status and contact with health services

129

305

2.13

12.49

1.0

256.37

364.76

ng/l

2.90

238

Malignant neoplasm of digestive organs, including Hilmo

1421

0.46

12.44

1.0

302.78

334.91

ng/l

0.48

997

Statin medication

245

816

1.69

12.39

1.0

284.13

394.55

ng/l

1.62

177

620

Suicide or other Intentional self-harm

117

567

2.07

12.36

1.0

246.76

308.99

ng/l

2.71

425

Other sleep disorders

273

2.58

12.28

1.0

309.50

323.52

ng/l

0.16

193

Other CVD (FINNGEN)

322

2.29

12.27

1.1

1.0

298.00

375.93

ng/l

1.53

235

Hypotension

110

524

2.11

12.18

1.1

1.0

292.21

323.43

ng/l

0.61

342

Malignant neoplasm of digestive organs

1326

0.44

12.17

1.0

304.89

336.43

ng/l

0.39

923

Parasetamol

288

899

1.62

12.09

1.0

274.45

344.61

ng/l

3.09

201

704

Other functional intestinal disorders

245

1364

1.64

11.90

1.0

290.97

372.43

ng/l

1.68

182

969

Dysphagia

152

818

1.87

11.89

1.0

283.44

330.53

ng/l

1.57

113

568

Substance abuse

283

1670

1.58

11.88

1.0

284.21

311.74

ng/l

1.08

216

1236

Hypertension, essential

368

1374

1.52

11.88

1.0

282.49

333.14

ng/l

1.52

285

1012

Degeneration of the brain due to alcohol

5.23

11.79

1.0

1.1

317.56

210.20

ng/l

1.08

Persistent mood disorders

421

2.22

11.72

1.0

260.17

341.08

ng/l

3.06

313

Alcohol use disorder, Swedish definition

275

1583

1.58

11.67

1.0

287.35

312.30

ng/l

0.88

209

1169

Symptoms and signs involving the urinary system

395

2028

1.47

11.63

1.0

309.57

342.95

ng/l

0.64

299

1452

Inflammatory diseases of the central nervous system

212

2.76

11.59

1.1

1.0

324.36

287.45

ng/l

0.33

143

Somnolence, stupor and coma

5.28

11.54

1.0

1.1

241.44

254.76

ng/l

0.10

Dorsopathies

429

1488

1.46

11.35

1.0

292.21

365.95

ng/l

1.97

301

1115

Behavioural syndromes associated with physiological disturbances and physical factors

430

2016

1.45

11.34

1.0

264.09

347.18

ng/l

3.87

326

1480

Sleep apnoea

461

2043

1.42

11.12

1.0

361.98

330.81

ng/l

0.17

344

1487

Vascular dementia (mixed)

10.23

11.05

1.0

1.1

296.79

251.54

ng/l

0.30

Cervicalgia

112

560

2.01

10.93

1.0

273.21

345.06

ng/l

2.13

419

Unspecified fall

249

1545

1.59

10.82

1.0

453.30

318.42

ng/l

0.47

184

1094

Other external causes of accidental injury

340

1125

1.52

10.76

1.0

299.69

340.41

ng/l

1.39

254

804

Other soft tissue disorders, not elsewhere classified

399

1559

1.46

10.70

1.0

280.81

353.06

ng/l

1.95

286

1141

Persistent delusional disorders

199

2.74

10.66

1.0

315.40

304.73

ng/l

0.09

134

All influenza

138

747

1.86

10.64

1.1

1.0

259.49

324.82

ng/l

2.94

534

Migraine without aura

281

2.43

10.59

1.0

255.38

328.01

ng/l

1.74

209

Transient ischemic attack

288

1502

1.53

10.41

1.0

288.62

341.53

ng/l

2.54

202

1054

Use of hypnotics and sedatives

495

2033

1.39

10.39

1.0

274.44

343.53

ng/l

2.91

384

1470

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

988

0.33

10.36

1.0

391.38

339.75

ng/l

0.20

676

Pain in limb

360

1558

1.47

10.33

1.0

270.63

353.20

ng/l

2.54

254

1140

Status epilepticus

3.97

10.32

1.0

269.87

308.53

ng/l

0.40

Spinal stenosis

281

1349

1.54

10.28

1.0

289.52

375.84

ng/l

2.02

181

1002

Other CVD

117

608

1.93

10.25

1.1

1.0

295.53

324.76

ng/l

0.61

405

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

832

0.33

10.15

1.0

286.67

341.59

ng/l

0.96

568

Accidents

335

1125

1.49

9.93

1.0

300.64

340.41

ng/l

1.32

249

804

Personality disorders

108

553

1.96

9.89

1.0

210.55

312.66

ng/l

8.27

418

Sleep disorders

405

1976

1.41

9.59

1.0

264.09

348.11

ng/l

3.84

310

1452

Malignant neoplasm of bronchus and lung, including Hilmo

745

0.32

9.34

1.0

296.39

342.75

ng/l

0.64

508

Hypertensive diseases

353

1374

1.45

9.32

1.0

290.58

333.14

ng/l

1.08

272

1012

Hypertension

353

1374

1.45

9.31

1.0

290.58

333.14

ng/l

1.08

272

1012

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

318

2.24

9.28

1.0

242.28

298.27

ng/l

1.82

234

Mental and behavioural disorders due to alcohol, excluding acute intoxication

222

1410

1.57

9.21

1.0

297.75

307.63

ng/l

0.22

171

1049

Dental operations

292

997

1.51

9.17

1.0

321.96

316.06

ng/l

0.12

201

717

Malignant neoplasm of respiratory system and intrathoracic organs

746

0.33

9.15

1.0

285.71

345.62

ng/l

0.94

510

Bleeding

416

2097

1.39

9.12

1.0

304.74

342.19

ng/l

0.98

289

1546

Influenza and pneumonia

463

2083

1.37

9.10

1.0

279.48

346.29

ng/l

2.60

349

1529

Phobic anxiety disorders

158

2.79

9.09

1.0

220.26

308.97

ng/l

2.42

119

Persons encountering health services in other circumstances, wide

518

1969

1.35

9.01

1.0

276.10

358.02

ng/l

3.44

425

1377

Transient global amnesia

149

2.84

8.94

1.0

337.72

227.89

ng/l

1.52

105

Stroke, including SAH

333

1660

1.44

8.91

1.0

309.09

331.83

ng/l

0.64

232

1188

Traumatic subarachnoid haemorrhage

6.85

8.84

1.1

1.0

357.88

230.52

ng/l

0.94

Sleep apnoea, including avohilmo

460

2046

1.36

8.57

1.0

364.90

333.03

ng/l

0.17

341

1489

Nerve, nerve root and plexus disorders

485

2160

1.35

8.56

1.0

304.01

338.41

ng/l

0.96

367

1564

Stroke, excluding SAH

315

1577

1.45

8.53

1.0

315.71

335.00

ng/l

0.48

221

1123

Diseases of oesophagus, stomach and duodenum

473

2066

1.35

8.46

1.0

292.96

335.19

ng/l

1.34

363

1504

Hyperplasia of prostate

200

704

1.61

8.41

1.0

272.89

298.42

ng/l

0.79

151

501

Disturbances of smell and taste

4.67

8.35

1.1

1.0

321.73

256.13

ng/l

0.38

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

166

2.67

8.34

1.1

1.0

271.50

311.69

ng/l

0.71

108

Alcohol use disorder, ICD-based

203

1307

1.56

8.33

1.0

296.76

303.97

ng/l

0.15

157

973

Other diseases of intestines

440

1795

1.37

8.32

1.0

297.41

344.78

ng/l

1.23

325

1312

Hyperkinetic disorders, excluding more controls

7.65

8.12

1.0

1.1

179.94

180.40

ng/l

0.01

Diseases of male genital organs

227

741

1.55

7.99

1.0

270.23

293.83

ng/l

0.81

178

532

Cardiodefibrillation

1364

0.49

7.97

1.0

254.04

329.97

ng/l

3.60

964

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

8.98

7.96

1.0

193.91

331.33

ng/l

—

All pneumoniae

444

2141

1.35

7.94

1.0

283.83

343.09

ng/l

2.17

335

1571

Malignant neoplasm of bronchus and lung

646

0.33

7.87

1.0

296.70

347.92

ng/l

0.62

435

Symptoms and signs concerning food and fluid intake

257

2.27

7.81

1.1

1.0

298.77

328.06

ng/l

0.41

175

Other and unspecified polyneuropathies, also in other diseases

114

644

1.78

7.81

1.1

1.0

262.24

315.56

ng/l

2.26

448

Rotator cuff syndrome

317

1542

1.42

7.76

1.0

313.99

354.61

ng/l

0.74

235

1129

Genitourinary diseases

234

773

1.52

7.68

1.0

280.90

313.24

ng/l

1.14

178

556

Heart failure and coronary heart disease

1207

0.55

7.62

1.0

257.27

336.21

ng/l

4.97

854

Periodontitis

459

2199

1.33

7.55

1.0

291.75

340.78

ng/l

1.66

335

1609

Mixed and other personality disorders

153

2.63

7.45

1.0

240.32

271.06

ng/l

0.52

116

Chronic periodontitis, including avohilmo

458

2202

1.33

7.42

1.0

292.90

340.64

ng/l

1.59

334

1612

Endocrine, nutritional and metabolic diseases

297

1045

1.44

7.39

1.0

274.66

355.69

ng/l

3.96

221

777

Injuries to the thorax

221

1491

1.48

7.31

1.0

284.43

326.86

ng/l

1.41

156

1085

Diseases of oral cavity, salivary glands and jaws

260

914

1.47

7.28

1.0

318.39

330.39

ng/l

0.25

178

652

Ischaemic Stroke, excluding all haemorrhages

291

1514

1.42

7.22

1.0

319.94

337.18

ng/l

0.35

205

1069

Biguanides

444

2020

1.33

7.15

1.0

284.75

349.13

ng/l

2.31

329

1488

Hypothyroidism, drug reimbursement

121

2.55

7.11

1.0

312.11

359.25

ng/l

0.45

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

431

2166

1.33

6.99

1.0

289.20

341.90

ng/l

1.77

328

1587

Fracture of skull and facial bones

549

1.79

6.95

1.0

246.21

319.00

ng/l

3.85

393

Specific personality disorders

457

1.87

6.87

1.0

207.11

318.65

ng/l

7.95

346

Pneumonia, organism unspecified

402

2068

1.33

6.84

1.0

291.07

346.89

ng/l

1.80

301

1518

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.38

6.80

1.1

1.0

348.82

289.69

ng/l

0.32

Pneumonias (Asthma/COPD co-morbidities)

435

2155

1.32

6.80

1.0

288.19

342.52

ng/l

1.86

331

1580

Other lack of coordination

5.75

6.80

1.2

1.0

248.67

297.83

ng/l

—

Fracture at wrist and hand level

149

937

1.59

6.77

1.1

1.0

292.57

318.99

ng/l

0.53

118

680

All kidney diseases

427

2169

1.32

6.73

1.0

300.08

338.49

ng/l

1.10

327

1577

Degeneration of nervous system due to alcohol

3.36

6.73

1.0

317.56

266.95

ng/l

0.40

Type 2 diabetes, wide definition

394

1863

1.34

6.66

1.0

282.31

353.36

ng/l

2.42

293

1369

Hypertensive diseases (excluding secondary)

202

783

1.50

6.56

1.0

270.12

334.12

ng/l

2.56

154

607

Later onset COPD

859

0.48

6.54

1.1

1.0

265.90

353.10

ng/l

2.31

566

305

2.04

6.52

1.0

222.84

348.00

ng/l

6.82

206

Retention of urine

180

962

1.52

6.47

1.1

1.0

345.71

327.99

ng/l

0.18

132

666

Volume depletion

253

2.15

6.46

1.1

1.0

241.94

340.82

ng/l

1.78

164

Lung cancer and mesothelioma

630

0.39

6.45

1.0

296.39

369.50

ng/l

1.16

435

Cystitis

350

1540

1.35

6.42

1.0

317.19

354.29

ng/l

0.58

260

1104

Insomnia

374

1954

1.33

6.38

1.0

264.81

348.69

ng/l

3.73

292

1435

Diabetes medication

442

1978

1.31

6.35

1.0

280.95

347.59

ng/l

2.43

328

1452

Systemic atrophies primarily affecting the central nervous system

114

2.75

6.29

1.1

1.0

292.00

307.70

ng/l

0.12

Vascular syndromes of brain in cerebrovascular disorders

3.47

6.29

1.1

1.0

270.79

222.56

ng/l

0.57

Diseases of the ear and mastoid process

470

1816

1.30

6.27

1.0

379.72

310.66

ng/l

0.44

346

1345

Migraine with aura

435

1.84

6.27

1.0

222.54

344.33

ng/l

6.97

319

Migraine without aura and triptan purchases

230

2.18

6.25

1.0

235.97

321.52

ng/l

2.94

174

Cervical disc disorders

175

1167

1.50

6.24

1.0

306.65

356.91

ng/l

0.73

129

883

Cervicocranial syndrome

270

2.09

6.23

1.0

267.51

350.62

ng/l

1.72

199

External causes of morbidity and mortality

252

884

1.43

6.22

1.0

297.41

351.50

ng/l

1.61

190

624

COPD, hospital admissions 1, only main diagnosis

1083

0.54

6.21

1.0

315.44

331.07

ng/l

0.16

754

Acute and transient psychotic disorders

258

2.10

6.16

1.0

242.61

307.96

ng/l

1.34

183

GASTRO-related operations

291

1051

1.39

6.13

1.0

313.05

318.99

ng/l

0.13

195

848

Any gastric operation

291

1051

1.39

6.13

1.0

313.05

318.99

ng/l

0.13

195

848

Exposure to unspecified factor

433

2270

1.30

6.12

1.0

318.89

335.77

ng/l

0.33

350

1628

Hypothyroidism, strict autoimmune, 3 medication purchases required

353

1777

1.34

6.11

1.0

293.36

355.37

ng/l

1.81

238

1311

Other bacterial diseases

425

2164

1.30

6.11

1.0

281.24

342.33

ng/l

2.36

311

1595

Fall involving bed

3.05

6.09

1.0

234.28

323.04

ng/l

1.14

Injuries to the abdomen, lower back, lumbar spine and pelvis

178

1180

1.49

6.08

1.0

303.02

326.36

ng/l

0.42

122

846

Fracture of rib(s), sternum and thoracic spine

155

1014

1.53

6.07

1.0

293.18

319.56

ng/l

0.52

109

729

COPD, hospital admissions

108

1481

0.61

6.06

1.0

296.60

334.66

ng/l

0.73

1038

Heart failure, strict

163

1692

0.67

6.05

1.0

254.16

342.46

ng/l

7.01

127

1174

Colorectal cancer, including Hilmo

1040

0.52

6.04

1.0

322.32

340.57

ng/l

0.16

711

All-cause Heart Failure

162

1677

0.67

5.92

1.0

255.05

343.53

ng/l

6.96

126

1161

COPD related to multimorbidity

1296

0.59

5.90

1.0

278.74

341.19

ng/l

1.64

896

Other/unspecified dorsalgia

157

1023

1.52

5.90

1.0

275.75

368.55

ng/l

1.72

116

766

COPD, early/later onset

111

1494

0.62

5.86

1.0

293.46

334.33

ng/l

0.84

1047

Polyneuropathies and other disorders of the peripheral nervous system

119

739

1.62

5.86

1.1

1.0

268.54

319.95

ng/l

2.22

523

Restless leg syndrome

410

1.84

5.84

1.0

270.87

327.11

ng/l

2.24

289

Non-small cell lung cancer, including Hilmo

555

0.35

5.84

1.0

327.19

334.03

ng/l

0.05

370

Implicit fungal Sepsis

3.03

5.81

1.1

1.0

267.22

347.22

ng/l

0.88

Colorectal cancer

952

0.50

5.77

1.0

333.91

346.37

ng/l

0.09

648

COPD, hospital admissions 3, with asthma pneumonia sepsis

840

0.50

5.75

1.1

1.0

279.86

329.11

ng/l

1.01

573

Continuous positive airway pressure

425

1.75

5.74

1.0

330.90

375.46

ng/l

0.67

309

Disturbance of activity and attention

3.59

5.68

1.0

179.94

216.47

ng/l

0.73

Missing teeth due to accident, extraction or parodontitis

315

2112

1.33

5.66

1.1

1.0

490.00

320.29

ng/l

0.71

211

1545

Other bacterial diseases, including avohilmo

431

2093

1.29

5.65

1.0

271.77

344.55

ng/l

3.14

311

1547

Pain in joint

244

1071

1.40

5.64

1.0

292.50

348.25

ng/l

2.23

187

800

Other drug-induced secondary parkinsonism

5.18

5.63

1.1

1.0

222.18

295.50

ng/l

0.72

Oter anti-inflammatory and antirheumatic agents, non-steroids

101

324

1.72

5.63

1.0

270.17

333.32

ng/l

1.78

235

Somatoform disorder

365

1.87

5.62

1.1

1.0

281.27

340.62

ng/l

1.81

259

Spondylosis

257

1459

1.38

5.61

1.0

295.74

369.31

ng/l

1.59

163

1095

Fibromyalgia

189

2.23

5.59

1.0

249.06

341.12

ng/l

2.89

139

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

447

1.77

5.57

1.0

287.35

308.60

ng/l

0.38

332

Diarrhoea and gastroenteritis of presumed infectious origin

283

1872

1.35

5.55

1.0

297.19

330.57

ng/l

0.73

220

1336

Injuries to the shoulder and upper arm

384

2287

1.30

5.53

1.0

384.93

325.34

ng/l

0.28

280

1673

Alcohol dependence

128

822

1.56

5.49

1.0

286.07

304.71

ng/l

0.38

102

607

Heart failure,strict

151

1563

0.67

5.47

1.0

251.77

342.20

ng/l

6.70

119

1101

Other (not insulin) diabetes medications

431

1975

1.28

5.46

1.0

278.62

348.73

ng/l

2.64

319

1451

Dental caries, including avohilmo

318

1215

1.34

5.45

1.0

327.16

324.95

ng/l

0.04

220

866

Other diseases of hard tissues of teeth

246

914

1.40

5.40

1.0

331.46

330.39

ng/l

0.02

173

652

Abnormalities of breathing

345

1497

1.32

5.39

1.0

370.54

332.78

ng/l

0.15

262

1082

Migraine with aura and triptan purchases

239

2.06

5.34

1.0

226.00

316.39

ng/l

4.51

176

Caries of dentine, including avohilmo

334

1288

1.33

5.33

1.0

322.21

323.50

ng/l

0.03

236

923

Sequelae of injuries, of poisoning and of other consequences of external causes

107

666

1.61

5.26

1.0

281.46

308.36

ng/l

0.68

491

Superficial injury of abdomen, lower back and pelvis

381

1.82

5.24

1.0

236.74

315.68

ng/l

2.40

271

Excessive earwax

303

2076

1.32

5.23

1.0

304.88

344.52

ng/l

0.96

199

1512

Bacterial infection, other or unspecified, including avohilmo

283

1736

1.34

5.17

1.0

286.05

354.09

ng/l

1.95

207

1248

Hypothyreosis and Thyroxine purchase for inclusion criteria

381

1938

1.29

5.15

1.0

288.89

353.47

ng/l

2.15

267

1425

Schizophrenia

377

1.81

5.11

1.0

227.71

317.98

ng/l

4.41

280

Explicit Sepsis

149

913

1.49

5.10

1.0

293.87

347.62

ng/l

1.60

102

588

Pain, not elsewhere classified

109

687

1.59

5.10

1.0

252.06

340.77

ng/l

5.42

507

Redundant prepuce, phimosis and paraphimosis

481

1.70

5.05

1.0

256.97

289.22

ng/l

0.84

345

Disorders of eyelid, lacrimal system and orbit

383

2192

1.28

5.05

1.0

305.78

341.77

ng/l

0.93

278

1600

Fungal Sepsis

2.78

5.05

1.1

1.0

267.22

344.40

ng/l

0.88

Meningitis

122

2.48

5.04

1.1

1.0

230.32

290.57

ng/l

0.72

Explicit Sepsis, including avohilmo

151

926

1.48

5.03

1.0

295.98

346.09

ng/l

1.47

104

598

Migraine

167

893

1.46

5.02

1.0

257.37

328.62

ng/l

3.79

126

658

Persons encountering health services for other counselling and medical advice, not elsewhere classified

466

1969

1.26

5.02

1.0

269.80

358.02

ng/l

3.91

379

1377

COPD

117

1450

0.65

4.99

1.0

288.74

331.01

ng/l

0.94

1013

Other chronic obstructive pulmonary disease

111

1401

0.65

4.98

1.0

293.46

332.77

ng/l

0.79

978

Visual disturbances and blindness

231

1693

1.37

4.97

1.0

384.14

340.34

ng/l

0.29

165

1213

Other and unspecified injuries of head

181

2.17

4.87

1.1

1.0

313.87

307.66

ng/l

0.04

118

Colorectal adenocarcinoma

805

0.50

4.85

1.0

325.29

341.14

ng/l

0.11

548

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

122

1425

0.66

4.84

1.0

352.18

346.55

ng/l

0.03

1058

Hyperkinetic disorders

3.20

4.80

1.0

179.94

209.06

ng/l

0.55

Hypothyroidism, other/unspecified

363

1863

1.28

4.76

1.0

285.74

354.42

ng/l

2.25

253

1372

Other problems related to primary support group, including family circumstances

146

2.27

4.75

1.0

256.39

300.99

ng/l

0.70

104

Diseases of the musculoskeletal system and connective tissue

178

619

1.44

4.74

1.0

274.32

347.86

ng/l

2.04

125

463

Diplopia

372

1.78

4.73

1.0

470.82

320.61

ng/l

0.33

262

Diseases of pulp and periapical tissues and dental caries

281

1081

1.33

4.72

1.0

333.84

321.79

ng/l

0.26

190

765

Disorders of parathyroid gland

592

1.61

4.71

1.0

286.87

340.58

ng/l

1.88

402

Primary hyperparathyroidism

337

1.82

4.68

1.0

290.09

335.88

ng/l

0.98

227

Special screening examination for infectious and parasitic diseases

232

1.86

4.61

1.0

276.94

302.89

ng/l

0.44

200

Disorders of other endocrine glands

172

1201

1.41

4.56

1.0

267.03

351.71

ng/l

1.86

134

851

Diabetes, insulin treatment (Kela reimbursement)

437

2087

1.25

4.50

1.0

284.44

345.96

ng/l

2.19

324

1531

COPD, hospital admission 2, with asthma infections

995

0.60

4.49

1.0

284.23

327.99

ng/l

0.66

687

Symptoms and signs involving the digestive system and abdomen

408

1623

1.26

4.48

1.0

314.67

326.69

ng/l

0.31

299

1184

Used for control exclusion in common control thyroid runs

424

1705

1.25

4.48

1.0

287.52

349.41

ng/l

1.79

307

1262

Hypothyroidism, strict autoimmune

306

1548

1.30

4.46

1.0

296.15

358.45

ng/l

1.45

208

1132

Disorders of the thyroid gland

387

1993

1.26

4.44

1.0

280.99

349.06

ng/l

2.47

273

1473

Disorders of lens

339

1642

1.28

4.43

1.0

305.84

348.68

ng/l

0.94

250

1233

Bacterial infection, other or unspecified

260

1664

1.32

4.43

1.0

284.59

336.19

ng/l

2.41

194

1184

Gastro-oesophageal reflux disease

309

2027

1.29

4.38

1.0

343.50

337.79

ng/l

0.04

221

1474

Disorders of vestibular function (Vertigo)

221

1603

1.35

4.37

1.0

459.34

331.86

ng/l

0.36

158

1147

Other disorders of fluid, electrolyte and acid-base balance

150

986

1.44

4.35

1.0

481.59

354.44

ng/l

0.23

111

663

Senile cataract

326

1544

1.29

4.35

1.0

309.05

357.37

ng/l

1.01

241

1145

Transport accidents

173

1028

1.40

4.34

1.0

279.02

325.62

ng/l

1.47

133

737

Hard cardiovascular diseases

394

1855

1.26

4.34

1.0

291.81

340.59

ng/l

1.43

290

1383

Cervicobrachial syndrome

621

1.57

4.32

1.0

237.95

389.35

ng/l

2.00

474

Dystonia

138

2.26

4.32

1.1

1.0

256.52

311.14

ng/l

1.18

Other chronic obstructive pulmonary disease, including avohilmo

154

1778

0.71

4.31

1.0

294.69

322.81

ng/l

0.62

117

1249

Disorders of choroid and retina

381

2127

1.26

4.28

1.0

326.70

339.96

ng/l

0.20

282

1541

Diseases of the myoneural junction and muscle

362

1.75

4.27

1.0

312.13

308.05

ng/l

0.04

247

Acute tubulo-interstitial nephritis

276

1793

1.30

4.25

1.1

1.0

313.43

355.66

ng/l

0.82

207

1258

Visual disturbances

211

1570

1.35

4.23

1.0

381.02

335.33

ng/l

0.28

153

1129

Unspecified urinary incontinence

255

1.89

4.20

1.0

265.69

327.02

ng/l

1.13

169

Urinary track infection

193

698

1.39

4.17

1.0

334.81

392.24

ng/l

0.51

140

514

Gingivitis and periodontal diseases

412

1713

1.24

4.07

1.0

306.91

350.46

ng/l

1.01

300

1250

Hypersomnia

4.27

4.03

1.1

1.0

298.33

267.40

ng/l

—

Hyperparathyroidism

516

1.60

4.02

1.0

296.95

339.38

ng/l

1.13

352

Polyuria

109

729

1.50

4.01

1.0

316.00

341.21

ng/l

0.49

507

Paracetamol or NSAID medication

128

1.93

4.00

1.0

246.32

392.70

ng/l

3.98

Soft tissue disorders

380

1559

1.25

3.94

1.0

295.77

353.06

ng/l

1.36

272

1141

Viral and other specified intestinal infections

311

1.76

3.93

1.1

1.0

273.67

301.41

ng/l

0.46

214

Diverticular disease of intestine

347

1721

1.26

3.91

1.0

304.16

350.29

ng/l

1.10

245

1254

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

399

1914

1.24

3.90

1.0

283.18

350.43

ng/l

2.26

297

1403

Neuromuscular dysfunction of bladder

234

1.89

3.87

1.1

1.0

496.55

312.91

ng/l

0.29

158

Injury, poisoning and certain other consequences of external causes

191

700

1.37

3.86

1.0

293.02

358.46

ng/l

1.63

135

507

Renal tubulo-interstitial diseases

369

2180

1.24

3.84

1.0

299.63

340.01

ng/l

1.17

284

1568

Oedema, not elsewhere classified

131

896

1.43

3.81

1.0

271.51

356.38

ng/l

4.39

105

643

Certain infectious and parasitic diseases, including avohilmo

299

1171

1.28

3.81

1.0

293.56

354.80

ng/l

1.15

211

860

Diabetes mellitus

408

1915

1.23

3.80

1.0

280.42

350.37

ng/l

2.48

308

1404

Peripheral arterial reconstruction

551

0.47

3.79

1.0

313.16

319.15

ng/l

0.04

365

Voice disturbances

117

804

1.46

3.78

1.0

398.01

334.50

ng/l

0.30

565

Asthma (mode)

316

1310

1.27

3.76

1.0

280.35

348.03

ng/l

3.69

236

942

Other diseases of pleura

117

1456

0.70

3.73

1.1

1.0

306.80

329.25

ng/l

0.32

1021

Hypoglycaemia, other or unspecified

154

2.09

3.72

1.1

1.0

338.64

287.81

ng/l

0.46

104

Injuries to the wrist and hand

415

2251

1.22

3.72

1.0

290.17

340.27

ng/l

1.71

325

1629

Cardiovascular diseases (excluding rheumatic etc)

187

788

1.36

3.71

1.0

275.89

333.32

ng/l

2.09

138

610

Weight loss

296

1.77

3.70

1.1

1.0

310.20

316.18

ng/l

0.06

201

Emotionally unstable personality disorder

168

2.03

3.68

1.0

201.74

282.49

ng/l

1.92

127

Abnormal findings in secretions and smears from cervix uteri vagina vulva

908

0.65

3.68

1.0

328.76

362.73

ng/l

0.27

688

Acute alcohol intoxication, ICD10

566

1.54

3.67

1.0

253.36

297.75

ng/l

1.24

423

Pain (limb, back, neck, head abdominally)

277

1080

1.29

3.67

1.0

291.70

348.42

ng/l

2.12

197

802

Chronic apical periodontitis

443

2045

1.22

3.64

1.0

377.65

328.62

ng/l

0.27

327

1482

Fracture of neck

176

2.00

3.64

1.1

1.0

377.08

302.49

ng/l

0.39

116

Atherosclerosis, excluding cerebral and coronary sclerosis

109

1237

0.69

3.63

1.0

308.17

338.19

ng/l

0.61

855

Subjective visual disturbances

108

738

1.47

3.61

1.1

1.0

361.16

324.96

ng/l

0.26

532

Diseases of inner ear

249

1857

1.28

3.61

1.0

468.13

329.31

ng/l

0.47

179

1342

Diabetes, varying definitions

405

1919

1.22

3.61

1.0

280.90

350.10

ng/l

2.44

306

1407

Benign paroxysmal vertigo

133

946

1.41

3.59

1.0

552.09

333.99

ng/l

0.37

671

Bacterial meningitis

2.52

3.55

1.1

1.0

209.77

290.54

ng/l

0.72

Fracture of lumbar spine and pelvis

658

1.49

3.54

1.0

348.84

338.34

ng/l

0.09

449

Superficial injury of hip and thigh

414

1.62

3.53

1.0

300.10

317.73

ng/l

0.21

282

Dipeptidyl peptidase 4 (DPP-4) inhibitors

273

1689

1.27

3.51

1.0

281.84

361.38

ng/l

2.34

191

1209

Malignant neoplasm of colon, including Hilmo

715

0.55

3.51

1.0

352.40

339.98

ng/l

0.07

485

Acute alcohol intoxication

108

743

1.46

3.50

1.0

268.52

304.21

ng/l

0.84

542

Pneumonitis due to solids and liquids

228

1.85

3.50

1.0

332.40

303.18

ng/l

0.30

149

Complications of surgical and medical care, not elsewhere classified

414

2276

1.21

3.49

1.0

396.69

321.44

ng/l

0.42

304

1666

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

364

1727

1.23

3.48

1.0

291.47

360.39

ng/l

2.02

276

1260

364

1727

1.23

3.48

1.0

291.47

360.39

ng/l

2.02

276

1260

Osteoporosis

123

796

1.42

3.48

1.0

309.86

346.48

ng/l

0.74

548

Use of biperiden

145

2.08

3.48

1.1

1.0

218.20

282.69

ng/l

1.53

Non-ischemic cardiomyopathy

999

0.66

3.43

1.0

273.21

352.62

ng/l

3.22

703

Other disorders of eye and adnexa

356

1.66

3.43

1.0

288.61

317.71

ng/l

0.40

248

Benign neoplasm: Sigmoid colon

657

1.48

3.42

1.0

284.62

324.49

ng/l

0.96

461

Other and unspecified myopathies

259

1.79

3.42

1.0

301.31

317.50

ng/l

0.17

173

Type 2 diabetes

402

1914

1.22

3.39

1.0

274.91

350.50

ng/l

2.86

304

1403

Other specific joint derangements/joint disorders

275

1354

1.27

3.39

1.0

290.80

317.91

ng/l

0.98

205

999

Fall on same level involving ice and snow

245

1924

1.27

3.39

1.0

462.51

325.09

ng/l

0.41

164

1402

Other disorders of glucose regulation and pancreatic internal secretion

195

1.91

3.38

1.1

1.0

328.13

293.94

ng/l

0.31

135

Later onset COPD, excluding more controls

640

0.59

3.37

1.0

251.87

370.62

ng/l

4.21

429

Irritable bowel syndrome

108

749

1.45

3.37

1.0

300.06

329.38

ng/l

0.68

533

Disorders of ocular muscles, binocular movement, accommodation and refraction

176

1312

1.33

3.37

1.0

318.09

337.26

ng/l

0.23

120

979

Malignant neoplasm of pancreas, including Hilmo

316

0.35

3.36

1.0

243.67

342.69

ng/l

—

203

Substance use, excluding alcohol

452

1.57

3.33

1.1

1.0

227.76

310.39

ng/l

4.55

338

Certain infectious and parasitic diseases

381

1561

1.22

3.32

1.0

301.38

342.75

ng/l

0.74

280

1135

Abnormal weight loss

277

1.74

3.29

1.1

1.0

300.13

313.32

ng/l

0.14

185

Injuries to the elbow and forearm

284

1950

1.25

3.27

1.0

322.62

341.71

ng/l

0.36

202

1432

Injuries to the neck

550

1.51

3.26

1.0

299.59

308.71

ng/l

0.08

400

Use of disulfiram, acamprosate or naltrexone

234

1.80

3.25

1.0

252.60

288.75

ng/l

0.56

174

Oxycodone

113

1355

0.71

3.24

1.0

281.38

347.44

ng/l

1.35

953

Viral and other specified intestinal infections, including avohilmo

453

1.55

3.23

1.1

1.0

276.60

307.19

ng/l

0.67

314

Diseases of the eye and adnexa

277

1100

1.26

3.22

1.0

301.39

337.76

ng/l

0.53

216

847

Cardiovascular diseases

164

643

1.35

3.21

1.0

259.24

318.74

ng/l

2.75

119

503

Injuries to the hip and thigh

208

1446

1.29

3.18

1.0

324.75

331.16

ng/l

0.11

140

1017

Fracture of forearm

229

1616

1.27

3.15

1.0

329.90

350.75

ng/l

0.32

165

1170

Diseases of tongue

144

2.02

3.15

1.1

1.0

296.63

348.34

ng/l

0.68

104

Other specified/unspecified disorders of bone/cartilage

2.56

3.13

1.0

303.58

249.27

ng/l

0.67

Finngen Rheumatological endpoints

371

1734

1.21

3.12

1.0

326.17

337.96

ng/l

0.15

276

1276

Disorders of synovium and tendon

219

1452

1.28

3.12

1.0

344.98

356.35

ng/l

0.14

170

1073

Insulin, intermediate and long-acting

232

1767

1.27

3.11

1.0

307.55

319.68

ng/l

0.24

169

1269

Alcohol abuse, main dg

421

1.57

3.10

1.0

241.95

300.57

ng/l

1.76

312

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

396

2080

1.20

3.08

1.0

300.66

337.95

ng/l

1.00

308

1526

Other disorders of penis

246

1.75

3.05

1.1

1.0

348.36

298.57

ng/l

0.52

171

Basal cell carcinoma

155

1400

0.75

3.04

1.1

1.0

313.94

342.92

ng/l

0.65

101

979

Tramadol

328

1612

1.22

3.02

1.0

274.35

341.13

ng/l

4.12

257

1163

Other meningitis

3.59

3.00

1.0

261.33

303.59

ng/l

—

Hypo-osmolality and hyponatraemia

549

1.49

2.99

1.0

216.97

354.01

ng/l

13.54

374

Pedestrian injured in transport accident

169

1.90

2.95

1.0

308.45

289.03

ng/l

0.11

112

Aortic aneurysm

838

0.63

2.95

1.0

298.70

334.02

ng/l

0.70

571

Malignant neoplasm of colon

578

0.55

2.93

1.0

364.50

333.60

ng/l

0.14

382

Pleural effusion

526

0.53

2.93

1.0

291.79

323.65

ng/l

0.41

354

Nausea and vomiting

103

711

1.42

2.92

1.0

315.19

335.52

ng/l

0.33

487

Assault by bodily force

121

2.07

2.92

1.1

1.0

238.20

258.46

ng/l

0.28

Other intracranial haemorrhages

2.34

2.92

1.1

1.0

178.83

333.08

ng/l

—

Other general symptoms and signs

2.39

2.91

1.0

226.75

299.02

ng/l

1.16

Exclusions for E4_PCOS_BROAD

420

1.55

2.90

1.0

237.32

314.02

ng/l

3.15

298

Psoriasis

900

0.64

2.90

1.0

330.81

324.87

ng/l

0.05

668

Basal cell carcinoma, including Hilmo

164

1449

0.76

2.89

1.1

1.0

311.74

340.70

ng/l

0.68

108

1018

malignant neoplasm of female genital organs, including Hilmo

573

0.56

2.89

1.1

1.0

343.22

385.54

ng/l

0.34

381

Asthma

311

1307

1.23

2.89

1.0

270.20

348.16

ng/l

5.01

237

940

Other disorders starting during childhood or adolescence

4.67

2.89

1.0

216.44

304.64

ng/l

—

Asthma, excluding more controls

301

1255

1.23

2.88

1.0

272.45

350.72

ng/l

4.77

230

905

Diseases of pulp and periapical tissues, including avohilmo

400

1729

1.20

2.87

1.0

325.36

325.79

ng/l

0.01

297

1238

Strabismus

639

1.44

2.87

1.0

305.02

325.22

ng/l

0.29

463

Intestinal infectious diseases, including avohilmo, including avohilmo

467

2207

1.18

2.85

1.0

301.37

340.28

ng/l

1.14

363

1591

Peripheral artery disease

123

1313

0.74

2.83

1.0

304.84

334.79

ng/l

0.68

910

Other disorders of nervous system

165

1.89

2.80

1.1

1.0

345.43

323.18

ng/l

0.09

115

Postmenopausal osteoporosis with pathological fracture

180

1.84

2.78

1.0

290.52

336.96

ng/l

0.67

117

Persons encountering health services in other circumstances

154

1161

1.31

2.77

1.0

298.09

364.33

ng/l

1.06

129

795

Anti-inflammatory and antirheumatic products, non-steroids

326

1.45

2.76

1.0

255.21

331.97

ng/l

2.89

237

Rheumatism, unspecified

402

1.55

2.76

1.0

313.86

346.52

ng/l

0.39

285

Cramp and spasm

111

2.08

2.73

1.1

1.0

312.59

281.32

ng/l

0.13

Abdominal and pelvic pain

386

1623

1.19

2.73

1.0

307.40

326.69

ng/l

0.58

284

1184

Caries of dentine

608

1.43

2.72

1.1

1.0

671.48

320.91

ng/l

0.50

453

Solid cancers

266

1910

0.82

2.70

1.0

405.27

321.83

ng/l

0.29

203

1401

Coronary artery bypass grafting

747

0.67

2.69

1.0

281.11

339.34

ng/l

1.78

528

Pain in thoracic spine

365

1.57

2.68

1.0

257.12

347.65

ng/l

2.42

277

Injury of muscle and tendon at shoulder and upper arm level

170

1321

1.29

2.67

1.0

307.44

313.99

ng/l

0.11

125

970

Hernia

379

2119

1.19

2.66

1.0

321.56

337.15

ng/l

0.15

266

1567

Non-rheumatic valve diseases

155

1434

0.77

2.66

1.0

303.19

330.65

ng/l

0.81

109

1024

Exclusions for E4_PCOS_CONSORTIUM

243

1222

1.24

2.63

1.0

476.00

332.73

ng/l

0.51

188

897

Anomalies of pupillary function

2.95

2.62

1.0

217.14

287.55

ng/l

—

Benign neoplasm of colon, rectum, anus and anal canal

304

2133

1.21

2.59

1.0

303.07

347.18

ng/l

1.25

223

1529

Malignant neoplasm of skin

182

1560

0.79

2.58

1.1

1.0

305.84

337.83

ng/l

0.83

124

1111

Symptoms and signs involving the circulatory and respiratory systems

357

1497

1.20

2.57

1.0

283.95

332.78

ng/l

2.76

272

1082

Benign neoplasm: Cerebral meninges

291

1.62

2.56

1.0

320.76

327.77

ng/l

0.05

193

Endovascular or surgical operations to intracerebral aneurysms

186

1.78

2.53

1.1

1.0

350.56

317.29

ng/l

0.19

124

Tonsillectomy and adenotomy

815

0.71

2.52

1.0

260.46

294.23

ng/l

1.12

631

Fracture of femur

113

754

1.35

2.48

1.0

332.46

335.46

ng/l

0.04

519

Valvular operations

548

0.58

2.48

1.0

343.85

332.19

ng/l

0.11

379

Type 1 diabetes

601

1.41

2.47

1.0

319.64

323.40

ng/l

0.05

436

Disorders of brain, other and unspecified

3.87

2.47

1.1

1.0

3433.62

263.54

ng/l

—

Other ill-defined and unspecified causes of mortality

263

1.64

2.47

1.0

365.15

320.11

ng/l

0.26

174

Inguinal hernia

239

1290

1.23

2.46

1.0

340.70

315.55

ng/l

0.18

168

948

Other symptoms and signs involving the circulatory and respiratory systems

173

1.80

2.45

1.0

339.78

317.18

ng/l

0.11

114

Vocal cord dysfunction

279

1.58

2.44

1.0

320.75

507.26

ng/l

0.81

211

Cough

171

1256

1.27

2.43

1.0

334.46

344.00

ng/l

0.16

132

894

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.40

2.42

1.0

212.83

268.63

ng/l

—

Gastrointestinal diseases

206

822

1.26

2.42

1.0

299.77

337.10

ng/l

0.95

142

601

Gout, strict definition

680

0.63

2.41

1.0

257.10

309.68

ng/l

1.36

471

Asthma, unspecified (mode), excluding more controls

215

1240

1.24

2.41

1.0

269.90

351.93

ng/l

4.73

168

894

Benign neoplasm of brain and other parts of central nervous system

167

1.81

2.40

1.1

1.0

310.28

302.05

ng/l

0.05

110

Valvular heart disease excluding rheumatic fever

158

1436

0.78

2.38

1.0

305.55

330.49

ng/l

0.72

112

1026

Osteopathies and chondropathies

236

1765

1.22

2.38

1.0

308.15

347.58

ng/l

0.79

169

1278

Examination and encounter for administrative purposes

175

1.78

2.37

1.0

341.69

373.54

ng/l

0.14

136

Other heart diseases

155

781

1.29

2.37

1.0

289.05

334.34

ng/l

1.40

122

605

2.63

2.36

1.0

288.29

293.19

ng/l

—

Family history of certain disabilities and chronic diseases leading to disablement

2.26

2.34

1.0

402.27

280.65

ng/l

0.48

Retinal detachments and breaks

162

1276

1.27

2.34

1.0

368.05

322.38

ng/l

0.53

126

898

Ill-defined and unknown causes of mortality

283

1.60

2.33

1.0

351.45

315.06

ng/l

0.22

189

938

0.71

2.33

1.1

1.0

292.64

350.71

ng/l

1.77

625

Benign neoplasm: Stomach

299

1.58

2.32

1.0

329.70

319.91

ng/l

0.09

199

Autoimmune diseases

424

1846

1.17

2.32

1.0

299.68

342.61

ng/l

1.11

306

1371

Propionic acid derivatives

326

1.41

2.31

1.0

272.04

331.97

ng/l

1.14

237

Liquid cancers, including Hilmo

110

1285

0.75

2.31

1.0

320.10

341.02

ng/l

0.28

896

Special screening examination for neoplasms

133

1.89

2.31

1.1

1.0

300.79

326.79

ng/l

0.23

109

Complications of other internal prosthetic devices, implants and grafts

119

1.95

2.31

1.0

553.50

314.79

ng/l

—

Myocardial infarction, strict

148

1338

0.78

2.30

1.0

299.15

335.17

ng/l

0.97

102

961

Mixed conductive and sensorineural hearing loss

380

1.51

2.29

1.1

1.0

329.44

317.13

ng/l

0.14

267

Calcific aortic valvular stenosis

990

0.71

2.29

1.0

319.26

333.21

ng/l

0.20

663

Calcific aortic valvular stenosis, operated

990

0.71

2.29

1.0

319.26

333.21

ng/l

0.20

663

Myocardial infarction, with ST-elevation

560

0.61

2.28

1.0

389.52

313.30

ng/l

0.59

386

Fibroblastic disorders

101

748

1.35

2.28

1.0

298.67

334.02

ng/l

0.87

548

COPD (mode)

939

0.73

2.28

1.0

298.71

352.33

ng/l

0.94

646

Operations 2 for CAVS

988

0.71

2.27

1.0

319.26

332.62

ng/l

0.19

661

Calcific aortic valvular stenosis, diagnosis (helper)

988

0.71

2.27

1.0

319.26

332.62

ng/l

0.19

661

Maternal care related to the fetus and amniotic cavity and possible delivery problems

606

0.70

2.26

1.0

266.71

375.40

ng/l

1.12

480

Evidence of alcohol involvement determined by level of intoxication

3.94

2.26

1.0

239.00

256.25

ng/l

—

Abnormal findings on diagnostic imaging of lung

147

1769

0.79

2.25

1.0

306.44

328.02

ng/l

0.51

117

1231

Oxicams

324

1.42

2.25

1.0

269.64

333.32

ng/l

1.78

235

Asthma, unspecified (mode)

219

1288

1.23

2.24

1.0

272.09

348.73

ng/l

4.35

170

925

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

393

2274

1.16

2.24

1.0

300.97

338.25

ng/l

1.07

313

1644

Benign neoplasm of meninges

318

1.55

2.24

1.0

318.59

324.18

ng/l

0.04

214

Disease of hard tissues of teeth, NOS

215

911

1.24

2.23

1.0

307.49

330.95

ng/l

0.60

163

650

Unstable angina pectoris

110

1139

0.76

2.22

1.0

272.44

339.13

ng/l

2.72

808

Colon adenocarcinoma

455

0.57

2.22

1.0

364.00

336.14

ng/l

0.11

297

Benign neoplasm: Colon

258

2016

1.20

2.21

1.0

296.22

349.99

ng/l

1.52

184

1438

Calcific aortic valvular stenosis, including rheumatic fever

991

0.72

2.19

1.0

320.59

333.59

ng/l

0.19

664

Eating disorders

114

1.93

2.19

1.0

277.80

284.58

ng/l

0.04

Type 2 diabetes, strict (exclude DM1)

384

1916

1.17

2.18

1.0

269.84

351.62

ng/l

3.23

283

1406

Intestinal infectious diseases

362

2304

1.17

2.18

1.0

301.47

339.06

ng/l

1.07

284

1665

Panic disorder

203

1.68

2.17

1.0

204.35

311.49

ng/l

5.52

146

Other disorders of lacrimal gland

154

1219

1.27

2.16

1.0

314.81

355.69

ng/l

0.54

112

870

malignant neoplasm of female genital organs

503

0.60

2.16

1.1

1.0

307.85

369.05

ng/l

0.93

330

Insulin medication

241

1656

1.21

2.16

1.0

311.58

346.76

ng/l

0.60

176

1192

L02BX Other hormone antagonists and related agents

199

0.40

2.16

1.1

1.0

537.13

319.40

ng/l

—

136

Impingement syndrome of shoulder

112

851

1.32

2.15

1.0

317.97

366.41

ng/l

0.45

628

Any reimbursement code in KELA

178

710

1.26

2.14

1.0

270.53

340.61

ng/l

2.90

134

530

Type 2 diabetes, definitions combined, including avohilmo

380

1886

1.17

2.14

1.0

268.55

352.11

ng/l

3.30

284

1383

Fall on and from stairs and steps

103

774

1.33

2.14

1.0

271.05

326.65

ng/l

2.18

549

Pain associated with micturition

354

1.50

2.13

1.1

1.0

274.37

318.41

ng/l

0.83

244

Malignant melanoma

574

0.63

2.13

1.0

287.70

339.92

ng/l

0.65

391

Malignant melanoma, including Hilmo

647

0.65

2.13

1.0

290.67

332.50

ng/l

0.55

441

Bacterial, viral and other infectious agents

189

1.70

2.13

1.0

299.55

258.70

ng/l

0.36

138

Other fall from one level to another

595

1.38

2.12

1.0

325.06

311.74

ng/l

0.11

432

COPD differential diagnosis

310

1310

1.19

2.12

1.0

286.24

348.03

ng/l

2.97

233

942

ILD differential diagnosis

310

1310

1.19

2.12

1.0

286.24

348.03

ng/l

2.97

233

942

Diagnoses used for exclusion with ILD

102

767

1.33

2.11

1.0

316.94

320.27

ng/l

0.05

540

Deviated nasal septum

141

1107

1.27

2.10

1.1

1.0

268.89

312.69

ng/l

1.80

110

817

Other malignant neoplasms of skin (=non-melanoma skin cancer)

171

1440

0.80

2.10

1.1

1.0

311.11

341.22

ng/l

0.73

114

1011

Diabetic retinopathy, excluding more controls

101

419

1.35

2.10

1.0

264.30

299.33

ng/l

0.89

308

Assault

244

1.60

2.09

1.1

1.0

270.06

285.77

ng/l

0.20

181

Candidiasis, including avohilmo

109

829

1.32

2.09

1.0

281.58

333.99

ng/l

2.04

595

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.00

2.07

0.0

1.0

—

329.63

—

Excluding asthma or asthma-COPD overlap

311

1319

1.18

2.05

1.0

284.03

347.93

ng/l

3.17

234

946

Other pulmonary diagnosis

311

1319

1.18

2.05

1.0

285.17

347.93

ng/l

3.08

234

946

Other gastritis (incl. Duodenitis)

728

1.34

2.05

1.0

336.05

334.96

ng/l

0.01

513

Psoriasis vulgaris

567

0.63

2.03

1.0

300.21

317.50

ng/l

0.15

416

Carbimazole or st.post thyroidectomy, condition for graves disease

567

0.63

2.03

1.0

255.53

342.85

ng/l

1.87

407

Supplementary factors related to causes of morbidity and mortality classified elsewhere

116

894

1.30

2.03

1.0

322.14

317.18

ng/l

0.05

645

Malignant neoplasm

276

1912

0.84

2.03

1.0

399.96

321.56

ng/l

0.28

210

1403

Malignant neoplasm of prostate, including Hilmo

102

793

0.76

2.03

1.0

282.86

301.31

ng/l

0.38

570

In situ neoplasms

100

1313

0.76

2.02

1.0

341.78

333.15

ng/l

0.13

899

Asthma (diagnoses ohter than nonallergic)

333

2306

1.17

2.02

1.0

290.72

341.38

ng/l

1.70

251

1675

Psoriatic arthropathies

287

0.49

2.01

1.0

234.67

326.80

ng/l

—

213

Type 2 diabetes, definitions combined

380

1910

1.16

2.00

1.0

268.16

350.89

ng/l

3.28

280

1401

Ocular pain

193

1.66

1.99

1.1

1.0

259.93

297.02

ng/l

0.54

131

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

212

1691

1.21

1.99

1.1

1.0

290.27

315.35

ng/l

0.87

175

1242

Nontraumatic intracranial haemmorrhage

577

1.37

1.99

1.0

330.23

338.26

ng/l

0.07

396

Myalgia

654

1.35

1.99

1.0

300.04

391.60

ng/l

0.76

481

Use of pramipexole

680

1.34

1.99

1.0

298.52

331.93

ng/l

0.64

482

Cardiomyopathy (excluding other)

476

0.61

1.97

1.0

270.68

309.18

ng/l

0.43

331

Other cataract

205

1255

1.22

1.96

1.0

312.92

373.40

ng/l

1.02

146

920

Other respiratory diseases principally affecting the interstitium

597

0.65

1.95

1.1

1.0

345.00

321.63

ng/l

0.18

408

Cardiomyopathy

656

0.67

1.94

1.0

289.74

326.59

ng/l

0.41

454

Renal failure

140

1494

0.80

1.94

1.0

309.67

334.35

ng/l

0.52

107

1040

Malignant immunoproliferative diseases

2.77

1.94

1.1

1.0

315.00

290.75

ng/l

—

Abnormal blood-pressure reading, without diagnosis

127

1.82

1.94

1.1

1.0

234.07

321.86

ng/l

1.36

Osteoporosis with pathological fracture (FG)

218

1.61

1.94

1.0

290.04

367.78

ng/l

1.48

143

Solid cancers, including Hilmo

279

1912

0.85

1.93

1.0

399.83

321.56

ng/l

0.28

214

1403

Hydrocele

306

1.51

1.92

1.0

283.03

311.61

ng/l

0.42

206

Asthma and allergy, excluding more controls

208

1.62

1.91

1.1

1.0

295.41

345.24

ng/l

0.66

143

Hyperlipidaemia, other/unspecified

176

1290

1.23

1.91

1.0

298.48

353.62

ng/l

1.80

139

880

Dental caries

678

1.32

1.90

1.1

1.0

643.91

330.09

ng/l

0.47

501

Meniscus derangement

241

1341

1.19

1.89

1.0

322.92

320.48

ng/l

0.05

190

988

Laparoscopic left hemicolectomy

0.00

1.88

0.0

1.0

—

255.97

—

Malignant neoplasm of bladder, including Hilmo

415

0.59

1.88

1.0

367.75

323.66

ng/l

0.58

270

Malignant neoplasm of prostate

102

786

0.77

1.88

1.0

287.60

302.62

ng/l

0.29

564

L04AC Interleukin inhibitors

139

0.36

1.88

1.0

252.40

264.38

ng/l

—

100

Malignant melanoma of skin

445

0.60

1.88

1.0

288.53

325.04

ng/l

0.28

296

Viral pneumonia

365

1.46

1.87

1.0

240.83

326.22

ng/l

3.08

258

Fissure and fistula of anal and rectal regions

739

1.31

1.87

1.0

280.03

328.24

ng/l

1.44

538

Allergic rhinitis

627

1.34

1.87

1.0

297.74

317.73

ng/l

0.36

460

All influenza (not pneumonia)

390

1.44

1.87

1.1

1.0

217.10

310.12

ng/l

5.75

276

Dysplasia of cervi uteri

375

0.64

1.86

1.0

320.70

346.54

ng/l

0.23

278

malignant neoplasm of male genital organs, including Hilmo

103

803

0.77

1.86

1.0

276.90

300.00

ng/l

0.56

578

Cardiomyopathies, Primary/intrinsic

468

0.62

1.85

1.0

270.68

316.61

ng/l

0.53

324

Visual impairment including blindness (binocular or monocular)

159

1.70

1.85

1.0

376.76

312.49

ng/l

0.59

104

Asthma and allergy

210

1.60

1.85

1.1

1.0

295.41

343.54

ng/l

0.64

147

Primary gonarthrosis, bilateral

180

1827

0.82

1.84

1.0

309.17

354.26

ng/l

0.97

131

1319

Malignant neoplasm

279

1912

0.85

1.83

1.0

399.69

321.56

ng/l

0.28

213

1403

Endometriosis

109

487

1.30

1.83

1.0

341.63

372.82

ng/l

0.36

350

Hemiplegia

115

1.83

1.82

1.0

242.50

291.49

ng/l

0.93

Other symptoms and signs involving the digestive system and abdomen

476

1.39

1.82

1.0

312.14

336.33

ng/l

0.33

334

Coxibs

325

1.36

1.82

1.0

257.00

332.57

ng/l

2.22

236

Bronchitis, not specified as acute or chronic

230

1.57

1.81

1.1

1.0

353.92

309.53

ng/l

0.27

155

Vasomotor and allergic rhinitis

122

941

1.27

1.80

1.0

285.02

309.75

ng/l

0.64

705

Bacterial, viral and other infectious agents, including avohilmo

199

1.61

1.80

1.0

299.55

269.36

ng/l

0.25

145

Antihypertensive medication - note that there are other indications

157

660

1.24

1.79

1.0

269.30

339.70

ng/l

2.18

106

518

Anterior Iridocyclitis

563

1.35

1.79

1.1

1.0

323.94

317.38

ng/l

0.09

411

Malnutrition

2.36

1.78

1.0

312.20

293.96

ng/l

—

Malignant neoplasm of skin, including Hilmo

201

1612

0.83

1.78

1.1

1.0

304.91

334.85

ng/l

0.83

141

1151

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

183

1491

0.83

1.77

1.1

1.0

310.69

339.15

ng/l

0.72

126

1053

Malignant melanoma of skin, including Hilmo

535

0.65

1.77

1.0

289.80

330.29

ng/l

0.43

362

Achilles tendinitis

288

1.50

1.76

1.0

308.06

332.31

ng/l

0.27

216

Inflammatory diseases of prostate (prostatitis)

362

1.44

1.76

1.1

1.0

445.21

310.94

ng/l

0.61

251

Glaucoma suspect

159

1298

1.23

1.76

1.0

376.84

322.52

ng/l

0.54

106

908

Other disorders of bladder

346

1.45

1.75

1.1

1.0

237.74

321.38

ng/l

2.75

229

Type of accident

105

818

1.29

1.74

1.0

328.90

320.03

ng/l

0.08

589

Glaucoma

252

1822

1.18

1.74

1.0

355.47

355.48

ng/l

0.00

174

1292

Other diseases of biliary tract

271

0.51

1.74

1.0

276.00

325.11

ng/l

—

192

Acute and subacute iridocyclitis

532

1.36

1.73

1.1

1.0

325.00

318.27

ng/l

0.09

393

Alcohol withdrawal state with delirium

217

1.57

1.73

1.0

244.31

317.16

ng/l

1.72

155

Enthesopathies of lower limb, excluding foot

644

1.32

1.73

1.0

305.90

383.19

ng/l

0.70

493

Peripheral artery operations in Hilmo

410

0.61

1.73

1.0

275.44

316.84

ng/l

0.35

271

Lung diseases due to external agents

389

1.42

1.71

1.0

334.44

314.67

ng/l

0.20

264

Postpartum haemorrhage

318

0.60

1.71

1.0

412.65

295.35

ng/l

0.80

257

Abnormalities of heart beat

137

1071

1.24

1.71

1.0

279.77

347.82

ng/l

3.23

105

747

Heart failure and antihypertensive medication

568

0.73

1.70

1.0

268.40

348.96

ng/l

2.51

435

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

1.92

1.70

1.0

371.83

292.93

ng/l

0.61

Other strabismus

498

1.36

1.69

1.0

315.61

327.79

ng/l

0.14

364

Diseases of arteries, arterioles and capillaries

221

1912

0.85

1.68

1.0

302.20

330.26

ng/l

0.86

161

1344

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

504

0.65

1.68

1.0

317.63

304.70

ng/l

0.10

365

Colon adenocarcinoma, helper endpoint

418

0.62

1.67

1.0

364.00

328.94

ng/l

0.15

282

Diabetes insipidus

2.84

1.66

1.1

1.0

219.57

314.56

ng/l

—

Chronic kidney disease

1062

0.77

1.65

1.0

313.96

344.87

ng/l

0.55

722

Insulin, fast-acting

131

1056

1.24

1.65

1.1

1.0

332.95

313.36

ng/l

0.27

104

761

Cardiac arrhythmias

197

1055

1.20

1.64

1.0

296.67

362.74

ng/l

1.07

150

793

Superficial injury of lower leg

677

1.30

1.63

1.0

279.68

336.71

ng/l

1.43

491

Other postsurgical states

189

1.59

1.62

1.0

164.25

315.32

ng/l

6.68

123

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

125

1005

1.25

1.62

1.0

235.71

333.22

ng/l

5.94

101

725

Reimbursement for rheumatic diseases

158

1897

0.83

1.62

1.0

359.27

339.16

ng/l

0.28

108

1385

Malignant neoplasm, including Hilmo

284

1911

0.86

1.62

1.0

394.22

321.50

ng/l

0.26

218

1402

Asthma (only as main-diagnosis), excluding more controls

265

1255

1.17

1.62

1.0

298.50

350.72

ng/l

1.85

189

905

Other disorders of the musculoskeletal system and connective tissue

462

1.37

1.61

1.1

1.0

286.64

320.94

ng/l

0.46

330

Ménière disease

278

1.48

1.61

1.0

281.85

321.41

ng/l

0.54

182

Gonarthrosis, primary, with knee surgery

210

1925

0.85

1.60

1.0

329.74

350.11

ng/l

0.34

138

1393

Insulin, combination of fast acting with intermediate-acting or long-acting

241

1872

1.17

1.59

1.0

311.58

319.01

ng/l

0.14

176

1338

Myocardial infarction, without ST-elevation

119

1332

0.80

1.58

1.0

300.38

333.53

ng/l

0.82

932

Carcinoma in situ of skin

262

0.53

1.58

1.1

1.0

349.00

323.94

ng/l

0.17

170

Abdominal aortic aneurysm (AAA)

285

0.56

1.58

1.0

267.88

319.40

ng/l

—

184

Insulin, fast-acting or short human

132

1071

1.23

1.58

1.1

1.0

331.32

310.66

ng/l

0.29

105

770

Melanocytic naevi, other sites/unspecified

209

0.48

1.58

1.0

283.60

293.12

ng/l

—

142

Persons encountering health services for specific procedures, not carried out

199

1.56

1.0

239.91

313.11

ng/l

1.72

136

Early onset COPD

799

0.74

1.56

1.0

318.02

326.73

ng/l

0.07

576

Status post-ami

763

0.76

1.56

1.0

294.76

341.88

ng/l

1.07

539

Anosmia

2.29

1.56

1.1

1.0

244.80

388.06

ng/l

—

Leisure time condition

474

1.35

1.55

1.0

337.00

318.38

ng/l

0.12

335

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

2.46

1.55

1.1

1.0

337.88

258.26

ng/l

—

Diabetic neuropathy

304

1.44

1.54

1.1

1.0

283.47

274.04

ng/l

0.13

223

Malignant neoplasm of breast, ER-negative, including Hilmo

735

0.74

1.54

1.0

915.76

366.63

ng/l

0.48

513

ILD medications: immunosuppressive drugs

188

2013

0.84

1.53

1.0

340.91

336.50

ng/l

0.06

144

1488

Asthma (only as main-diagnosis)

271

1307

1.16

1.53

1.0

302.71

348.16

ng/l

1.54

194

940

malignant neoplasm of male genital organs

105

795

0.79

1.53

1.0

286.33

300.75

ng/l

0.29

572

107

1.78

1.53

1.0

296.30

336.51

ng/l

—

Radiculopathy

441

1.36

1.53

1.1

1.0

251.90

343.40

ng/l

3.68

324

Other mycoses, not elsewhere classified/unspecified, including avohilmo

0.00

1.53

0.0

1.0

—

300.04

—

Any event in cancer register

286

1918

0.87

1.52

1.0

385.78

324.08

ng/l

0.22

223

1405

Covid-19 suspected case

450

1.36

1.52

1.0

285.16

306.44

ng/l

0.31

332

Fitting and adjustment of other devices

157

1146

1.21

1.52

1.0

368.76

345.43

ng/l

0.43

113

763

Complications of procedures, not elsewhere classified

320

2262

1.14

1.50

1.0

426.31

322.24

ng/l

0.46

235

1656

Papulosquamous disorders

110

1366

0.80

1.50

1.0

329.62

345.39

ng/l

0.17

998

Malignant neoplasm of heart, mediastinum and pleura

0.00

1.50

0.0

1.0

—

339.52

—

Portal vein thrombosis

0.00

1.50

0.0

1.0

—

270.00

—

Other interstitial pulmonary diseases

514

0.68

1.50

1.1

1.0

370.17

320.19

ng/l

0.38

345

Psoriatic and enteropathic arthropathies

332

0.60

1.49

1.0

256.08

313.37

ng/l

1.33

248

Disorders of sclera, cornea, iris and ciliary body

207

1766

1.17

1.48

1.0

304.14

331.86

ng/l

0.52

155

1278

Chronic gastritis

114

919

1.24

1.48

1.0

296.22

339.91

ng/l

0.97

633

COPD/asthma related infections

389

1727

1.13

1.47

1.0

292.16

360.39

ng/l

2.04

288

1260

COPD/asthma/ILD related infections

389

1727

1.13

1.47

1.0

292.16

360.39

ng/l

2.04

288

1260

L04AX Other immunosuppressants

158

1886

0.84

1.47

1.0

344.44

330.58

ng/l

0.18

120

1374

Periapical abscess

183

1547

1.18

1.46

1.0

304.94

326.18

ng/l

0.29

143

1149

Second line medication for Crohn's disease

161

1917

0.84

1.46

1.0

341.34

330.18

ng/l

0.15

123

1399

Interstitial lung disease endpoints

511

0.68

1.46

1.1

1.0

370.17

321.01

ng/l

0.37

343

Interstitial lung disease

511

0.68

1.46

1.1

1.0

370.17

321.01

ng/l

0.37

343

Type 1 diabetes, wide definition, subgroup 1

471

1.34

1.44

1.0

322.79

320.82

ng/l

0.02

344

Disorders of skin appendages

166

1386

1.19

1.44

1.0

296.63

336.84

ng/l

0.60

119

1025

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

389

2220

1.12

1.43

1.0

303.90

339.83

ng/l

0.95

301

1605

Malignant neoplasm, wide definition

288

1914

0.87

1.43

1.0

395.19

321.39

ng/l

0.28

222

1404

Anorexia (incl.atypical)

1.97

1.43

1.1

1.0

220.83

302.86

ng/l

—

Disorders of lacrimal system

177

1471

1.18

1.43

1.0

309.87

360.87

ng/l

0.88

123

1064

Presence of other devices

104

820

1.25

1.43

1.0

378.42

340.05

ng/l

0.52

548

Vitamin deficiency

110

1.73

1.43

1.0

250.71

316.49

ng/l

0.91

Vitamin deficiency, wide

110

1.73

1.43

1.0

250.71

316.49

ng/l

0.91

Heterophoria

172

1.57

1.42

1.0

296.69

295.68

ng/l

0.01

117

Palmar fascial fibromatosis [Dupuytren]

499

1.33

1.42

1.0

284.29

335.94

ng/l

1.37

357

Atrial fibrillation and flutter with reimbursement

647

0.78

1.41

1.0

315.31

353.66

ng/l

0.60

491

Functional dyspepsia

101

808

1.25

1.41

1.0

268.51

334.19

ng/l

2.53

578

Left ventricular outflow tract obstruction (LVOTO), broad definition

302

0.59

1.41

1.0

275.92

298.67

ng/l

0.13

225

Polyarthropathies

244

1354

1.16

1.41

1.0

326.80

319.06

ng/l

0.10

186

998

Viral hepatitis, including avohilmo

149

1.62

1.40

1.0

235.29

261.74

ng/l

0.47

107

Sub-endpoint used in defining T1D endpoints

673

1.27

1.40

1.0

315.52

308.39

ng/l

0.10

483

Biological medication for rheuma

399

0.65

1.40

1.0

260.81

311.16

ng/l

1.32

299

Autoimmune diseases excluding thyroid diseases, strict definition

372

1797

1.13

1.39

1.0

314.30

345.48

ng/l

0.66

282

1331

Other and unspecified nerve root and plexus disorders, also in other diseases

632

1.28

1.39

1.0

300.34

318.59

ng/l

0.26

472

Special screening examination for other diseases and disorders

213

1.50

1.39

1.0

362.54

330.48

ng/l

0.19

166

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1001

0.80

1.39

1.1

1.0

698.28

324.56

ng/l

0.52

747

Hypertensive Heart Disease

681

0.77

1.39

1.1

1.0

310.80

357.55

ng/l

0.83

464

ILD, hospital admissions

505

0.69

1.39

1.1

1.0

370.17

321.58

ng/l

0.37

340

Malignant neoplasm of breast, HER-negative

685

0.74

1.38

1.0

974.17

371.11

ng/l

0.48

470

Postpartum hemorraghe, parous women as controls

303

0.63

1.38

1.0

412.65

320.64

ng/l

0.56

244

Ulcer of oesophagus

206

1.51

1.37

1.0

259.61

296.56

ng/l

0.60

133

Injury of muscle and tendon at wrist and hand level

373

1.37

1.0

254.41

312.54

ng/l

1.52

276

L02BB Anti-androgens

299

0.60

1.37

1.0

309.45

320.06

ng/l

0.07

195

Allergic asthma (mode)

490

1.32

1.36

1.0

326.81

342.33

ng/l

0.14

353

Retinal detachment with retinal break

425

1.34

1.36

1.1

1.0

493.09

304.90

ng/l

1.00

294

Budesonide

382

1.36

1.0

316.88

320.40

ng/l

0.03

280

Malignant neoplasm of head and neck, including Hilmo

359

0.64

1.35

1.0

274.69

321.23

ng/l

0.84

239

Mesothelioma

0.00

1.35

0.0

1.0

—

347.58

—

Hernia of abdominal wall

133

1598

0.83

1.34

1.0

273.00

319.70

ng/l

1.61

102

1161

Personal history of other diseases and conditions

158

1.58

1.34

1.0

280.17

304.92

ng/l

0.31

106

Colonic or urogenital fistula

100

805

1.24

1.34

1.0

291.31

328.18

ng/l

0.94

582

Iridocyclitis

627

1.28

1.34

1.1

1.0

318.42

321.10

ng/l

0.04

454

Unspecified haematuria

174

1201

1.18

1.34

1.0

316.59

322.11

ng/l

0.10

129

846

Chronic lower respiratory diseases

453

2148

1.11

1.34

1.0

282.89

343.56

ng/l

2.36

345

1565

Tumor necrosis factor alpha inhibitors

358

0.64

1.33

1.0

268.00

310.10

ng/l

0.87

268

672

0.75

1.33

1.0

327.86

339.00

ng/l

0.15

441

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

593

0.72

1.32

1.0

302.39

333.04

ng/l

0.50

407

Benign neoplasm of other and unspecified endocrine glands

410

1.34

1.32

1.0

243.05

323.01

ng/l

2.65

286

Autoimmune diseases excluding thyroid diseases

381

1844

1.12

1.32

1.0

311.37

342.72

ng/l

0.68

289

1370

Other noninfective gastroenteritis and colitis

646

1.27

1.31

1.0

252.39

331.74

ng/l

4.28

463

Inflammation of lacrimal passages (acute and unspecified)

0.00

1.31

0.0

1.0

—

303.64

—

Intracerebral haemorrhage

359

1.37

1.31

1.0

369.61

332.03

ng/l

0.31

236

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

709

1.26

1.31

1.0

317.84

320.67

ng/l

0.03

522

Myocardial infarction

172

1411

0.85

1.31

1.0

295.29

332.44

ng/l

1.20

121

1019

Other maltreatment syndromes

2.10

1.30

1.0

290.33

235.87

ng/l

—

Actinic keratosis

119

1309

0.83

1.30

1.0

340.14

358.42

ng/l

0.29

885

Ganglion

586

1.28

1.30

1.0

399.00

391.62

ng/l

0.04

432

Malignant neoplasm of head and neck

294

0.61

1.29

1.0

283.33

326.61

ng/l

0.56

187

Tongue abnormality

177

1.53

1.29

1.1

1.0

302.76

305.25

ng/l

0.02

117

Other pleural conditions

318

0.63

1.28

1.2

1.0

541.31

315.47

ng/l

0.69

206

Diaphragmatic hernia

151

1274

1.19

1.28

1.0

278.33

339.46

ng/l

1.96

903

Polycystic ovarian syndrome, consortium definition

221

1096

1.16

1.28

1.0

285.87

384.42

ng/l

2.00

156

812

Carcinoma in situ of skin of other and unspecified parts of face

255

0.59

1.26

1.1

1.0

394.60

322.30

ng/l

—

163

Tinnitus

731

1.25

1.26

1.0

327.85

329.90

ng/l

0.02

543

Preterm labour and delivery

633

1.27

1.26

1.0

341.15

367.44

ng/l

0.17

480

Mouth breathing

154

1302

1.18

1.25

1.0

277.41

311.83

ng/l

1.25

120

957

Allergic asthma (mode), excluding more controls

497

1.30

1.25

1.0

326.81

345.88

ng/l

0.18

355

Other arthrosis

229

1335

1.15

1.25

1.0

287.67

320.93

ng/l

1.18

176

983

Cerebral palsy and other paralytic syndromes

286

1.40

1.25

1.0

238.97

308.28

ng/l

2.44

192

Abnormal findings on examination of blood, without diagnosis

192

1497

1.16

1.24

1.0

297.62

320.77

ng/l

0.67

146

1069

Ankylosing spondylitis

203

1.48

1.24

1.0

293.18

316.73

ng/l

0.25

153

Other menopausal disorders

475

0.77

1.24

1.0

294.27

373.87

ng/l

1.39

345

Extreme obesity with alveolar hypoventilation

119

0.42

1.24

1.0

176.80

307.89

ng/l

—

Gout, unspecified

756

0.77

1.24

1.1

1.0

287.24

314.73

ng/l

0.43

532

Hypothermia

2.01

1.23

1.0

297.11

270.19

ng/l

—

Dialysis, with operation codes

422

0.69

1.23

1.0

328.96

308.60

ng/l

0.20

310

Biomechanical lesions, not elsewhere classified

139

1.59

1.23

1.0

234.75

308.46

ng/l

1.64

Nephropathy related operations

386

0.67

1.23

1.0

321.80

307.96

ng/l

0.12

280

Hypogonadotropic hypogonadism

1.97

1.22

1.0

174.00

203.60

ng/l

0.50

Congenital deformities of hip

2.64

1.21

1.0

1.1

318.00

328.21

ng/l

—

Coxarthrosis

230

1295

1.15

1.21

1.0

326.65

323.42

ng/l

0.03

157

952

Spirochaetal infections, other/unspecified

271

1.41

1.21

1.1

1.0

248.62

314.48

ng/l

1.60

189

Postmenopausal atrophic vaginitis

481

0.78

1.21

1.0

302.16

375.30

ng/l

1.30

346

Acetic acid derivatives and related substances

325

1.27

1.21

1.0

275.73

332.57

ng/l

1.14

236

Benign neoplasm of other and ill-defined parts of digestive system

575

1.27

1.21

1.0

306.13

333.31

ng/l

0.40

406

Other retinal disorders

269

1806

1.13

1.20

1.0

303.01

329.16

ng/l

0.83

188

1276

Hypertrophic disorders of skin

101

1.69

1.19

1.1

1.0

199.70

293.44

ng/l

—

Keratitis

126

1054

1.20

1.19

1.0

283.43

317.86

ng/l

0.85

772

Other disorders of the genitourinary system

375

1.34

1.18

1.0

417.95

342.95

ng/l

0.87

256

Insulin, fast-acting (human)

281

1.39

1.18

1.1

1.0

280.60

312.88

ng/l

0.59

198

Atypical facial pain

133

1.58

1.17

1.0

275.69

301.15

ng/l

0.34

Benign mammary dysplasia

367

1.34

1.17

1.0

362.11

343.61

ng/l

0.13

261

Diseases of arteries, arterioles and capillaries (FINNGEN)

611

0.79

1.16

1.0

298.25

353.10

ng/l

1.39

463

Aneurysms, operations, SAH

472

1.29

1.16

1.0

333.16

334.26

ng/l

0.01

331

Fentanyl

321

0.65

1.16

1.0

386.60

368.58

ng/l

0.05

216

Liquid cancers

1096

0.82

1.16

1.0

330.50

339.54

ng/l

0.10

750

Heart failure and bmi 25plus

782

0.82

1.16

1.0

234.86

332.16

ng/l

4.86

545

Open wound of wrist and hand

152

1252

1.17

1.16

1.0

261.83

314.65

ng/l

2.97

119

928

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

2.54

1.16

1.2

1.1

325.20

274.38

ng/l

—

Car occupant injured in other and unspecified transport accidents

420

1.31

1.15

1.1

1.0

298.17

310.94

ng/l

0.13

301

Malignant neoplasm of bladder

223

0.58

1.15

1.0

359.43

337.42

ng/l

—

139

Pulmonary eosinophilia, not elsewhere classified

0.00

1.15

0.0

1.0

—

304.60

—

Burns classified according to extent of body surface involved

2.52

1.15

1.0

190.80

276.17

ng/l

—

ILD, hospital admission 2, with pulmonary infections

320

0.65

1.14

1.0

323.92

339.30

ng/l

0.07

220

134

1421

0.85

1.14

1.0

337.75

353.62

ng/l

0.27

967

Ulcer of lower limb, not elsewhere classified

461

0.71

1.14

1.1

1.0

330.12

319.06

ng/l

0.09

321

Hypoparathyroidism

1.69

1.14

1.0

254.30

323.87

ng/l

—

Nonspecific lymphadenitis

155

0.51

1.13

1.0

288.13

301.76

ng/l

—

114

Seropositive rheumatoid arthritis, strict definition

449

0.71

1.13

1.0

364.54

328.21

ng/l

0.33

315

Fracture of shoulder and upper arm

134

1133

1.18

1.12

1.0

281.02

325.35

ng/l

1.06

814

Erosion of teeth , including avohilmo

599

1.25

1.12

1.0

349.79

306.63

ng/l

0.48

435

Adhesive capsulitis of shoulder

528

1.27

1.12

1.0

357.00

342.94

ng/l

0.16

387

Abnormal spermatozoa

482

0.72

1.11

1.0

479.59

310.80

ng/l

0.49

344

Gout, idiopatic and unspecified

921

0.80

1.11

1.0

288.39

320.54

ng/l

0.67

643

Other and unspecified follicular disorders

1.71

1.11

1.0

287.80

264.14

ng/l

—

Fracture of lower leg, including ankle

212

1827

1.14

1.10

1.0

285.43

349.94

ng/l

1.78

157

1322

Disorders of breast

157

1186

1.17

1.10

1.0

312.80

376.73

ng/l

0.97

122

862

Nasal polyp

628

1.24

1.10

1.0

274.32

314.05

ng/l

1.00

452

Hypokalaemia

363

1.33

1.09

1.1

1.0

943.08

347.73

ng/l

0.41

246

Chronic diseases of tonsils and adenoids

228

1629

0.88

1.09

1.0

321.79

312.20

ng/l

0.20

176

1214

Personal history of risk-factors, not elsewhere classified

2.39

1.09

1.0

175.20

337.17

ng/l

—

Cerebral aneurysm, nonruptured

260

1.39

1.09

1.0

378.70

325.95

ng/l

0.43

182

Problems related to lifestyle

243

1.40

1.09

1.0

270.14

320.12

ng/l

1.05

165

Type 1 diabetes, wide definition

503

1.27

1.09

1.0

323.64

323.56

ng/l

0.00

361

Congenital deformities of hip, including avohilmo

2.38

1.09

1.0

318.00

323.27

ng/l

—

Other disorders of bone

495

1.27

1.09

1.0

278.18

318.25

ng/l

1.11

361

Superficial injury of thorax

407

1.30

1.08

1.0

272.27

320.20

ng/l

0.87

288

Viral hepatitis

144

1.53

1.08

1.0

226.67

264.10

ng/l

0.69

103

Hypertrophic scar

1.69

1.07

1.1

1.0

174.33

292.67

ng/l

—

Complications of medical and surgical care

285

2294

1.12

1.06

1.0

430.38

324.66

ng/l

0.41

213

1662

Dilated cardiomyopathy

385

0.70

1.06

1.0

276.81

309.45

ng/l

0.33

272

Enlarged lymph nodes

391

1.31

1.06

1.0

299.38

338.00

ng/l

0.77

283

Episcleritis

121

1.58

1.05

1.1

1.0

337.36

287.09

ng/l

0.73

ILD, hospital admissions 3, with pneumonia sepsis

265

0.64

1.04

1.1

1.0

363.56

329.64

ng/l

—

174

Colectomy operation

533

0.75

1.04

1.0

346.67

321.44

ng/l

0.15

371

Unspecified acute lower respiratory infection

410

1.29

1.04

1.0

234.27

306.92

ng/l

2.62

295

Impacted cerumen

358

1.32

1.03

1.0

283.84

317.42

ng/l

0.39

248

Disorder of lipoprotein metabolism, unspecified

446

1.28

1.03

1.0

301.58

348.69

ng/l

0.74

293

Paralytic strabismus

204

1.43

1.03

1.0

242.94

320.24

ng/l

0.94

133

Gastroduodenal ulcer

101

840

1.20

1.02

1.0

309.35

338.08

ng/l

0.63

586

Diseases of liver

1184

0.84

1.02

1.0

313.06

316.77

ng/l

0.04

868

Other and unspecified tonsillitis

548

1.23

1.02

1.0

274.19

289.78

ng/l

0.23

422

Inflammatory diseases of female pelvic organs

192

1150

1.14

1.02

1.0

305.71

378.91

ng/l

1.18

145

838

Benign neoplasms

343

1688

1.11

1.02

1.0

316.71

311.05

ng/l

0.14

265

1224

Toxic effects of substances chiefly nonmedicinal as to source

281

1.35

1.01

1.0

283.33

311.19

ng/l

0.40

198

Follow-up examination after treatment for malignant neoplasms

213

1.41

1.01

1.1

1.0

320.43

347.92

ng/l

0.32

153

Appendectomy

175

1902

0.87

1.01

1.0

280.38

326.95

ng/l

1.22

138

1402

Abnormal findings on diagnostic imaging of other body structures

450

0.73

1.01

1.0

285.92

336.55

ng/l

0.74

310

Other diseases of upper respiratory tract

415

1974

1.10

1.01

1.0

300.17

327.45

ng/l

1.14

304

1426

Other specified and unspecified retinal disorders

1.66

1.00

1.0

450.56

262.00

ng/l

—

Urticaria

735

1.21

1.00

1.0

286.08

321.94

ng/l

0.92

541

Fenamates

237

1.32

1.00

1.0

399.26

331.26

ng/l

0.64

167

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

175

1464

1.14

1.00

1.0

317.81

342.27

ng/l

0.34

132

1079

Allergic conjunctivitis

181

1525

1.14

1.00

1.0

318.38

340.30

ng/l

0.31

137

1124

Seropositive rheumatoid arthritis

870

0.81

1.00

1.0

362.65

340.16

ng/l

0.27

601

Orchitis and epididymitis

239

1.38

1.00

1.0

290.88

304.71

ng/l

0.19

164

Obstructed labour due to maternal pelvic abnormality

413

1.29

0.99

1.1

1.0

453.95

399.76

ng/l

0.15

308

Opioids

345

1614

1.10

0.99

1.0

278.44

340.97

ng/l

3.86

264

1164

Lichen sclerosus et atrophicus

326

1.32

0.98

1.0

304.37

339.55

ng/l

0.39

231

Chronic ulcer of skin, not elsewhere classified

200

0.60

0.98

1.1

1.0

256.29

303.65

ng/l

—

136

Acute drug-induced interstitial lung disorder

0.00

0.98

0.0

1.0

—

325.21

—

Leiomyosarcoma, including Hilmo

0.00

0.98

0.0

1.0

—

381.84

—

Other viral diseases, not elsewhere classified, including avohilmo

544

1.24

0.98

1.0

284.74

308.70

ng/l

0.34

400

Asthma, hospital admissions , main diagnosis only

288

2258

1.11

0.98

1.0

301.87

339.88

ng/l

1.00

206

1654

Striking against or struck by other objects

103

864

1.19

0.98

1.0

297.48

301.20

ng/l

0.06

637

Type 1 diabetes, wide definition, subgroup 2

0.00

0.98

0.0

1.0

—

283.93

—

Certolizumab pegol

0.00

0.98

0.0

1.0

—

325.10

—

Codeine

330

1614

1.10

0.97

1.0

374.47

340.97

ng/l

0.12

247

1164

Coxarthrosis [arthrosis of hip](FG)

256

1576

1.12

0.97

1.0

336.55

344.08

ng/l

0.07

176

1152

Other and unspecified vascular occlusions

275

1.35

0.97

1.0

285.81

299.76

ng/l

0.15

176

Melanoma of uvea

0.00

0.97

0.0

1.0

—

315.35

—

Asthma, hospital admission 2, infections

204

1761

1.13

0.96

1.0

289.62

340.49

ng/l

1.13

147

1258

Asthma-related infections

204

1761

1.13

0.96

1.0

289.62

340.49

ng/l

1.13

147

1258

Antenatal screening

200

0.70

0.96

1.0

251.10

279.03

ng/l

0.57

174

Procreative management

637

1.20

0.96

1.0

313.65

312.17

ng/l

0.01

478

Polyarthrosis

706

1.20

0.96

1.0

322.82

353.55

ng/l

0.33

498

Diseases of external ear

131

1126

1.16

0.96

1.0

297.84

325.41

ng/l

0.56

813

Excessive attrition of teeth

212

1864

1.13

0.95

1.0

294.70

328.60

ng/l

0.76

158

1387

Combined immunodeficiencies

0.00

0.95

0.0

1.0

—

300.05

—

Noninfective enteritis and colitis

156

1358

1.15

0.95

1.0

281.04

344.25

ng/l

1.26

113

988

Superficial injury of wrist and hand

452

1.26

0.94

1.0

276.80

320.81

ng/l

0.74

329

Corneal ulcer

479

1.25

0.94

1.0

234.68

312.01

ng/l

2.61

350

Other diseases of oesophagus

268

1.35

0.94

1.0

239.36

315.48

ng/l

1.30

174

Melanocytic naevi

856

0.82

0.93

1.0

265.78

328.19

ng/l

1.63

621

Dermatitis and eczema

419

2278

1.09

0.93

1.0

284.80

342.05

ng/l

2.24

310

1663

Primary open-angle glaucoma, strict

107

905

1.18

0.93

1.0

411.48

331.34

ng/l

0.58

611

Coxarthrosis, primary, with hip surgery

163

1722

0.88

0.93

1.0

387.01

334.92

ng/l

0.48

107

1215

Atopic dermatitis, strict definition

504

1.24

0.93

1.0

259.35

313.72

ng/l

1.86

374

Dislocation, sprain and strain of joints and ligaments at neck level

312

1.32

0.93

1.0

247.71

308.70

ng/l

1.14

227

Pain and other conditions associated with female genital organs and menstrual cycle

348

1.27

0.93

1.1

1.0

283.62

352.48

ng/l

1.51

267

Speech therapy

789

1.19

0.92

1.0

306.99

324.98

ng/l

0.12

553

Brachial plexus disorders

192

1.41

0.92

1.0

288.24

286.38

ng/l

0.02

143

Myocardial infarction, unclassifiable

606

0.79

0.92

1.0

303.15

320.19

ng/l

0.26

400

Skin changes due to chronic exposure to nonionizing radiation

129

1351

0.86

0.92

1.0

339.02

355.91

ng/l

0.27

911

Generalized epilepsy, strict definition

2.15

0.91

1.0

222.67

238.61

ng/l

—

Traumatic amputation of wrist and hand

126

1.51

0.91

1.0

314.31

305.87

ng/l

0.06

Other follicular disorders

159

1.45

0.91

1.0

296.53

279.51

ng/l

0.14

115

Thyroiditis, ILD-related definition

261

1.34

0.91

1.1

1.0

285.48

327.39

ng/l

0.46

188

Hypertensive heart and/or renal disease

728

0.83

0.91

1.0

303.08

372.85

ng/l

1.35

493

Conjunctivitis

256

1855

1.11

0.91

1.0

307.22

343.56

ng/l

0.73

191

1362

Exposure to other specified factors

291

2265

1.10

0.90

1.0

413.86

311.72

ng/l

0.43

228

1658

Chronic sinusitis

153

1336

1.14

0.90

1.0

284.72

316.36

ng/l

1.03

116

974

Sudden idiopathic hearing loss

302

0.69

0.90

1.0

375.25

300.87

ng/l

0.65

210

140

1207

1.15

0.90

1.0

288.59

348.32

ng/l

0.90

103

874

Open wound of forearm

231

0.65

0.90

1.0

300.11

298.15

ng/l

—

158

Chronic rhinitis, nasopharyngitis and pharyngitis

114

976

1.17

0.89

1.0

618.56

318.54

ng/l

0.46

713

Spondylopathies (FG)

323

1.30

0.89

1.0

280.55

308.63

ng/l

0.42

241

Mycoses, including avohilmo

339

2358

1.09

0.89

1.0

282.09

340.10

ng/l

2.42

243

1733

Wet age-related macular degeneration

531

0.78

0.88

1.1

1.0

265.35

339.52

ng/l

1.52

332

Lesion of sciatic nerve

111

1.54

0.87

1.0

250.56

293.93

ng/l

—

Female infertility, cervical, vaginal, other or unspecified origin

404

0.79

0.87

1.0

280.95

348.32

ng/l

1.79

299

Collagenous colitis

263

1.33

0.87

1.0

276.81

321.31

ng/l

0.72

177

Other protozoal intestinal diseases, including avohilmo

1.87

0.87

1.1

1.0

342.13

278.52

ng/l

—

Dissociative [conversion] disorders

1.86

0.87

1.0

264.13

317.70

ng/l

—

Other bacterial intestinal infections, including avohilmo

666

1.20

0.87

1.0

295.33

325.11

ng/l

0.60

463

Disorders of conjunctiva

290

2041

1.10

0.87

1.0

311.83

339.81

ng/l

0.58

218

1497

Haemorrhage from respiratory passages

138

1063

1.15

0.87

1.0

290.58

342.11

ng/l

1.58

106

734

L02BG Aromatase inhibitors

1040

0.84

0.86

1.0

326.43

391.27

ng/l

0.78

736

Any death

291

1850

1.10

0.86

1.0

534.46

310.54

ng/l

1.02

209

1329

Presbyopia

221

1.36

0.85

1.0

337.64

294.62

ng/l

0.24

159

Pleural plaque

333

0.72

0.85

1.1

1.0

253.74

325.34

ng/l

1.01

214

Other enthesopathies

112

963

1.16

0.84

1.0

312.53

358.14

ng/l

0.52

714

Varicose veins

211

1775

0.90

0.84

1.0

331.30

345.37

ng/l

0.22

136

1300

ILD, hospital admissions 1, main diag only

446

0.76

0.84

1.1

1.0

370.17

324.05

ng/l

0.34

301

Secondary hypertension

210

1.36

0.83

1.1

1.0

319.91

384.05

ng/l

0.67

154

Allergic contact dermatitis

318

1.29

0.83

1.0

336.13

326.54

ng/l

0.07

225

Spondylolisthesis/Spondylolysis

533

1.22

0.83

1.0

256.56

343.06

ng/l

3.66

397

Other/unspecified seropositive rheumatoid arthritis

843

0.83

1.0

366.00

334.92

ng/l

0.43

593

Chronic laryngitis and laryngotracheitis

434

1.25

0.83

1.1

1.0

365.62

320.56

ng/l

0.57

311

Other specified and unspecified personality disorders

188

1.39

0.83

1.1

1.0

206.52

277.01

ng/l

1.58

131

Chronic periodontitis, complicated

242

2134

1.11

0.82

1.0

287.95

333.05

ng/l

1.36

184

1560

Gonarthrosis

263

1346

1.10

0.82

1.0

304.77

319.93

ng/l

0.38

189

991

Viral conjunctivitis

1.88

0.82

1.0

280.83

300.85

ng/l

—

Acute nasopharyngitis (common cold)

299

1.30

0.81

1.0

221.60

283.20

ng/l

1.31

228

Ankylosing spondylitis, ICD10

223

1.35

0.81

1.0

293.18

291.74

ng/l

0.01

159

Small fibre neuropathy

1.58

0.81

1.1

1.0

155.11

305.07

ng/l

—

Sulfonylureas

105

969

0.86

0.81

1.0

344.12

353.81

ng/l

0.09

670

Seropositive rheumatoid arthritis, wide

851

0.83

0.80

1.0

362.65

335.31

ng/l

0.37

599

Excessive vomiting in pregnancy

130

1.46

0.80

1.1

1.0

273.85

339.27

ng/l

0.84

Other respiratory disorders and diseases

643

0.81

0.80

1.1

1.0

257.87

321.82

ng/l

1.60

438

Other diseases of the respiratory system

643

0.81

0.80

1.1

1.0

257.87

321.82

ng/l

1.60

438

L04AA Selective immunosuppressants

632

0.81

0.80

1.0

375.63

327.54

ng/l

0.55

464

Sequelae of injuries of upper limb

276

1.31

0.80

1.1

1.0

270.55

309.59

ng/l

0.63

193

Chronic iridocyclitis

122

1.48

0.80

1.0

368.85

308.73

ng/l

0.43

Other diseases of liver

554

0.79

0.80

1.0

288.33

315.72

ng/l

0.30

407

Melanoma in situ of lower limb, including hip

0.00

0.79

0.0

1.0

—

287.53

—

Major coronary heart disease event excluding revascularizations

231

1684

0.90

0.79

1.0

276.75

328.84

ng/l

2.66

164

1223

Glaucoma secondary to eye inflammation

0.00

0.79

0.0

1.0

—

272.87

—

Other bacterial intestinal infections

509

1.22

0.79

1.0

292.56

323.44

ng/l

0.58

350

Sarcoidosis

383

1.26

0.79

1.0

306.98

322.13

ng/l

0.22

271

Use of glatiramer acetate

0.00

0.79

0.0

1.0

—

232.42

—

Blindness, monocular

0.00

0.79

0.0

1.0

—

330.00

—

Alcohol abuse counselling and surveillance

1.83

0.79

1.2

1.0

201.00

270.48

ng/l

—

Postpartum hemorraghe, all women as controls

309

0.73

0.79

1.0

412.65

303.78

ng/l

0.72

250

Gastric ulcer

564

1.21

0.79

1.0

299.06

336.76

ng/l

0.63

380

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

156

1.41

0.79

1.0

287.88

335.53

ng/l

0.55

Malignant neoplasm of eye and adnexa

0.00

0.79

0.0

1.0

—

322.58

—

Corticotropin deficiency

0.00

0.79

0.0

1.0

—

320.37

—

Aspergillosis

0.00

0.78

0.0

1.0

—

260.24

—

Myeloproliferative diseases

270

0.70

0.78

1.0

244.21

312.07

ng/l

1.47

181

Pulmonary heart disease, diseases of pulmonary circulation

1064

0.85

0.78

1.0

266.17

334.97

ng/l

2.72

749

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

447

0.77

0.78

1.0

298.23

336.23

ng/l

0.43

288

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.51

0.78

1.0

471.60

366.97

ng/l

—

Other inflammation of eyelid

420

1.24

0.78

1.1

1.0

279.09

325.38

ng/l

1.34

295

Aspergillosis, including avohilmo

0.00

0.78

0.0

1.0

—

251.33

—

Congenital malformations of aortic and mitral valves

0.50

0.77

1.0

258.00

240.25

ng/l

—

Malignant neoplasm of breast, HER2-negative

128

943

0.87

0.77

1.0

583.88

355.67

ng/l

0.42

100

684

Acute gastritis

208

1.35

0.77

1.0

304.14

310.58

ng/l

0.07

135

Other/unspecified enthesopathies, not elsewhere classified

243

1.32

0.77

1.0

308.26

339.54

ng/l

0.36

173

Rheumatoid arthritis, including avohilmo

111

1276

0.87

0.77

1.0

355.61

321.68

ng/l

0.63

902

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

140

1.43

0.76

1.1

1.0

320.60

324.19

ng/l

0.03

105

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

0.00

0.76

0.0

1.0

—

320.55

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.76

0.0

1.0

—

295.40

—

Varus deformity, not elsewhere classified

0.00

0.76

0.0

1.0

—

394.40

—

Intracranial and intraspinal abscess and granuloma

0.00

0.76

0.0

1.0

—

323.28

—

Acute pharyngitis

293

1.29

0.76

1.0

282.23

297.13

ng/l

0.14

217

Accidental poisoning by and exposure to alcohol

0.00

0.76

0.0

1.0

—

277.94

—

Malignant neoplasm of breast, HER-positive

105

903

0.86

0.76

1.0

317.38

359.42

ng/l

0.82

650

Diseases of middle ear and mastoid

125

1163

0.88

0.75

1.0

320.32

313.76

ng/l

0.10

851

Hydronephrosis

359

0.75

1.0

320.95

321.08

ng/l

0.00

239

Other and unspecified injuries of wrist and hand

1.60

0.75

1.1

1.0

240.17

283.67

ng/l

0.38

Frostbite

2.10

0.74

1.0

345.80

286.00

ng/l

—

Phakomatoses, not elsewhere classified

2.10

0.74

1.2

1.0

191.00

310.47

ng/l

—

Other disorders of veins

129

1440

0.88

0.74

1.0

390.48

341.69

ng/l

0.38

1068

Polypectomy (DHB20)

201

1.35

0.74

1.0

244.61

307.80

ng/l

1.41

137

Acne vulgaris

1.66

0.74

1.1

1.0

203.89

226.29

ng/l

—

Injuries to the ankle and foot

202

1907

0.90

0.74

1.0

288.96

324.31

ng/l

0.80

163

1417

Other diseases of blood and blood-forming organs, wide

690

0.83

0.74

1.0

295.04

331.33

ng/l

0.64

494

Temporomandibular joint disorders, including avohilmo

124

1054

1.14

0.73

1.0

304.87

344.77

ng/l

0.47

798

Cellulitis

652

1.18

0.73

1.0

296.62

315.37

ng/l

0.28

470

Disorders of refraction and accommodation

677

1.18

0.73

1.0

333.13

310.19

ng/l

0.29

505

Malignant neoplasm of breast, including Hilmo

130

945

0.88

0.73

1.0

573.92

355.12

ng/l

0.41

102

686

Presence of other functional implants

226

1701

0.91

0.73

1.0

307.43

358.54

ng/l

1.07

161

1211

Malignant neoplasm of breast, HER2-negative, including Hilmo

130

945

0.88

0.73

1.0

573.92

355.12

ng/l

0.41

102

686

Ventral hernia

786

0.84

0.72

1.1

1.0

270.81

335.52

ng/l

1.43

569

Other disorders of prostate

1.53

0.72

1.0

223.63

301.38

ng/l

—

Hypertrophy of breast in women and men

488

1.21

0.72

1.0

299.00

327.11

ng/l

0.38

352

Conjunctivitis (acute, non atopic)

715

1.17

0.71

1.0

280.06

326.62

ng/l

0.87

519

Malignant neoplasm of breast

129

943

0.88

0.71

1.0

579.74

355.67

ng/l

0.42

101

684

Endometriosis of rectovaginal septum and vagina

168

1.37

0.71

1.0

378.31

390.77

ng/l

0.06

120

Malignant neoplasm of breast, ER-positive, including Hilmo

106

904

0.87

0.71

1.0

315.49

359.19

ng/l

0.88

651

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

100

868

1.15

0.70

1.0

623.36

318.42

ng/l

0.44

633

Haemorrhage in early pregnancy

555

1.19

0.70

1.1

1.0

363.30

335.08

ng/l

0.36

417

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

827

0.85

0.70

1.0

366.00

334.99

ng/l

0.43

583

Subarachnoid haemorrhage

300

1.27

0.70

1.0

339.88

320.12

ng/l

0.12

202

Other disorders of skin and subcutaneous tissue

285

2214

1.09

0.70

1.0

316.37

344.23

ng/l

0.59

195

1616

Corns and callosities

186

1.35

0.70

1.1

1.0

304.93

307.55

ng/l

0.02

123

Non-allergic asthma (mode)

549

1.19

0.69

1.0

293.45

357.34

ng/l

1.20

382

Diseases of the respiratory system

237

1081

1.10

0.69

1.0

302.95

352.22

ng/l

1.34

169

770

Pregnancy with abortive outcome

162

943

0.89

0.69

1.0

368.73

380.26

ng/l

0.09

113

689

Diseases of the skin and subcutaneous tissue

363

1689

1.08

0.69

1.0

299.69

352.11

ng/l

1.29

261

1232

Appendicitis, broad definition

223

2190

0.91

0.69

1.0

276.49

329.26

ng/l

1.85

178

1623

Other shoulder lesions

239

1.30

0.69

1.0

297.32

339.19

ng/l

0.47

172

Bell's palsy

346

1.24

0.68

1.0

318.11

315.94

ng/l

0.02

243

Assault by unspecified means

1.86

0.68

1.0

292.60

250.89

ng/l

—

Erysipelas, including avohilmo

291

1988

1.08

0.68

1.0

279.33

347.27

ng/l

2.41

202

1457

Atrophic disorders of skin

437

1.21

0.68

1.0

316.23

344.38

ng/l

0.32

309

Pulmonary heart disease

995

0.86

0.68

1.0

259.81

327.30

ng/l

2.84

699

Plantar fascial fibromatosis

275

1.27

0.68

1.0

317.11

342.77

ng/l

0.27

194

Pilonidal cyst

144

1.39

0.67

1.0

228.14

266.12

ng/l

0.56

102

Acute renal failure

780

0.85

0.67

1.0

306.90

318.47

ng/l

0.13

540

Other female pelvic inflammatory diseases

401

1.22

0.67

1.0

297.08

358.04

ng/l

0.90

284

Polyarthritis, unspecified

102

1.48

0.67

1.0

315.00

297.87

ng/l

—

Degenerative macular diseases

365

1.23

0.67

1.0

317.85

322.18

ng/l

0.04

237

Pulmonary embolism

994

0.86

0.67

1.0

259.81

327.35

ng/l

2.84

700

Other hammer toe(s) (acquired)

561

0.83

0.67

1.0

371.67

364.32

ng/l

0.05

390

Acute sinusitis

167

1366

1.11

0.67

1.0

281.14

336.82

ng/l

0.96

121

1008

Carpal tunnel syndrome

236

1872

1.09

0.67

1.0

314.56

337.70

ng/l

0.43

176

1374

DVT of lower extremities

616

0.83

0.66

1.0

356.29

321.75

ng/l

0.39

442

Diseases of appendix

226

2205

0.92

0.66

1.0

278.82

329.54

ng/l

1.75

181

1628

Bicuspidal aortic valve syndrome

0.52

0.66

1.0

258.00

241.46

ng/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.79

0.66

1.0

418.20

295.11

ng/l

—

Other and unspecified urticaria

466

1.20

0.66

1.0

252.87

326.49

ng/l

2.48

334

Irregular menses

129

859

1.13

0.66

1.0

251.99

374.27

ng/l

2.21

654

Thyrotoxicosis with diffuse goitre

339

0.77

0.65

1.0

256.84

335.69

ng/l

1.03

248

Female infertility

409

0.83

0.65

1.0

284.64

349.51

ng/l

1.74

302

Injuries to the knee and lower leg

433

2192

1.07

0.65

1.0

293.40

343.41

ng/l

1.57

324

1588

Primary open-angle glaucoma

125

1068

1.13

0.64

1.0

397.13

331.99

ng/l

0.54

718

Neuralgia and neuritis, unspecified

137

1.39

0.64

1.0

214.64

318.81

ng/l

2.24

Asthma mixed form (mode)

128

0.62

0.64

1.0

461.50

351.35

ng/l

—

Asthma mixed form (mode), excluding more controls

130

0.61

0.63

1.0

461.50

354.35

ng/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

146

1.37

0.63

1.1

1.0

320.60

322.32

ng/l

0.01

109

Use of antiglaucoma preparations and miotics

207

1.31

0.63

1.1

1.0

278.10

310.66

ng/l

0.39

135

Other diseases of the digestive system

117

1037

1.13

0.63

1.0

303.12

330.43

ng/l

0.68

731

Arthrosis

268

1353

1.09

0.63

1.0

305.83

319.29

ng/l

0.32

193

997

Other necrotizing vasculopathies (FG)

181

1.33

0.63

1.0

349.47

323.07

ng/l

0.23

122

Urticaria and erythema

109

962

1.13

0.63

1.0

285.04

320.09

ng/l

1.09

706

Ectopic pregnancy

447

0.80

0.62

1.0

270.92

402.64

ng/l

0.96

342

Demyelinating diseases of the central nervous system

164

1.34

0.62

1.2

1.0

233.50

294.38

ng/l

1.00

115

Polymyalgia rheumatica

435

0.80

0.61

1.0

343.19

325.88

ng/l

0.17

286

Lateral epicondylitis

379

1.22

0.61

1.0

320.72

335.73

ng/l

0.12

283

UC patients in KELA-register (code 208), prior to 1994

130

1.39

0.61

1.1

1.0

454.36

283.49

ng/l

0.63

Other condition

379

1.22

0.61

1.0

310.24

316.58

ng/l

0.07

274

Other contact dermatitis

182

1.32

0.61

1.1

1.0

337.33

307.76

ng/l

0.18

125

Conduction disorders

106

960

0.88

0.61

1.0

284.25

345.97

ng/l

2.91

671

Other medical care

158

1464

0.90

0.60

1.0

692.86

333.51

ng/l

0.76

104

1011

Other symptoms and signs involving the urinary system

316

1.24

0.60

1.1

1.0

265.09

310.58

ng/l

0.63

219

Serous carcinoma of ovary

0.00

0.60

0.0

1.1

—

367.92

—

Other metabolic disorders

316

1.24

0.60

1.0

265.66

354.71

ng/l

1.18

222

Lung transplant status

0.00

0.60

0.0

1.0

—

286.23

—

Lung transplantation

0.00

0.60

0.0

1.0

—

286.23

—

Other and unspecified disorders of pigmentation

0.00

0.60

0.0

1.1

—

258.08

—

Recurrent and persistent haematuria

0.00

0.60

0.0

1.1

—

290.00

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

0.00

0.60

0.0

1.0

—

242.57

—

Benign neoplasm: Vulva

1.57

0.60

1.0

397.50

358.57

ng/l

—

Inflammatory bowel disease

834

1.14

0.60

1.0

296.61

323.40

ng/l

0.44

628

Infarction of spleen

0.00

0.60

0.0

1.0

—

307.14

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.60

0.0

1.0

—

279.57

—

Scleritis and episcleritis

139

1.37

0.60

1.1

1.0

337.36

286.02

ng/l

0.77

101

Acute mastoiditis

0.00

0.60

0.0

1.0

—

316.18

—

Other injuries of spine and trunk, level unspecified

0.00

0.60

0.0

1.0

—

281.27

—

Atopic dermatitis, strict definition with reimbursement

559

1.17

0.60

1.0

256.72

314.58

ng/l

1.87

424

Use of cabergoline

0.00

0.60

0.0

1.0

—

293.50

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.60

0.0

1.0

—

272.27

—

Zoster [herpes zoster]

564

1.17

0.60

1.1

1.0

247.96

342.76

ng/l

4.31

394

Lichen ruber planus, wide definition including periferal and oral lichen planus

741

1.15

0.60

1.0

331.08

330.29

ng/l

0.01

542

Other noninflammatory disorders of vagina

174

1.32

0.60

1.0

288.47

374.71

ng/l

0.94

129

Haemorrhage, not elsewhere classified

1.50

0.59

1.1

1.0

338.50

303.26

ng/l

—

Pediculosis, acariasis and other infestations, including avohilmo

362

1.22

0.59

1.0

317.66

300.92

ng/l

0.18

264

Atlantoaxial subluxation

0.00

0.59

0.0

1.0

—

339.69

—

Cervical root disorders

0.00

0.59

0.0

1.0

—

292.46

—

Complications peculiar to reattachment and amputation

0.00

0.59

0.0

1.0

—

276.27

—

Carcinoma in situ of breast, lobular

0.00

0.59

0.0

1.0

—

346.69

—

Anuria and oliguria

0.00

0.59

0.0

1.0

—

301.71

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.59

0.0

1.0

—

247.45

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.59

0.0

1.0

—

269.46

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

0.59

0.0

1.0

—

281.94

—

Melanocytic naevi of lip

0.00

0.59

0.0

1.0

—

313.13

—

Other viral diseases, including avohilmo

818

1.14

0.59

1.0

289.65

307.68

ng/l

0.27

624

Other congenital malformations of upper alimentary tract

0.00

0.58

0.0

1.0

—

283.38

—

Leiomyosarcoma

0.00

0.58

0.0

1.0

—

295.14

—

Fibrosis of liver

0.00

0.58

0.0

1.0

—

294.69

—

Use of entacapone

0.00

0.58

0.0

1.0

—

311.14

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

410

0.80

0.58

1.1

1.0

306.78

323.69

ng/l

0.10

288

Assault by sharp object

0.00

0.58

0.0

1.0

—

231.76

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

398

0.80

0.58

1.0

307.96

309.15

ng/l

0.01

287

Medicines for HER+ breast cancer

109

1140

0.89

0.58

1.0

321.51

383.58

ng/l

0.88

817

Congenital malformations of great arteries

0.00

0.58

0.0

1.0

—

299.77

—

Ovarian cyst

487

1.14

0.58

1.1

1.0

679.06

372.82

ng/l

0.40

350

Asthma, including avohilmo

428

2218

1.06

0.58

1.0

280.21

342.31

ng/l

2.58

317

1619

All dysplastic lesions of the cervix uteri

381

0.80

0.57

1.0

282.74

322.95

ng/l

0.70

297

Other and unspecified effects of external causes

641

1.16

0.57

1.0

308.85

312.72

ng/l

0.05

473

Raynaud syndrome

211

1.28

0.57

1.0

341.68

291.61

ng/l

0.28

140

Tooth eruption problems

119

1.38

0.57

1.0

254.09

264.07

ng/l

0.09

Alcoholic liver disease

353

0.79

0.57

1.0

321.35

295.51

ng/l

0.18

257

Open wound of shoulder and upper arm

1.67

0.56

1.2

1.0

305.33

287.38

ng/l

—

Umbilical hernia

872

0.87

0.56

1.0

302.71

308.18

ng/l

0.07

650

Other and unspecified visual disturbances

301

1.23

0.56

1.0

440.86

318.83

ng/l

0.33

206

Macular cyst

1.43

0.56

1.1

1.0

390.89

287.17

ng/l

—

Superficial injury of forearm

229

1.27

0.56

1.0

276.67

299.06

ng/l

0.34

159

Early onset COPD, excluding more controls

689

0.85

0.56

1.0

318.02

343.87

ng/l

0.24

497

Viral pneumonia (known virus, not influenza)

1.51

0.56

1.0

263.50

315.74

ng/l

—

Venous thromboembolism

180

1891

0.92

0.56

1.0

305.97

349.13

ng/l

0.90

128

1350

First line medication for Crohn's disease

356

2040

0.94

0.56

1.0

380.97

319.88

ng/l

0.27

267

1488

Endometriosis ASRM stages 1,2

338

1.21

0.55

1.0

339.35

351.14

ng/l

0.09

250

Glucagon-like peptide-1 (GLP-1) analogues

1093

0.89

0.55

1.1

1.0

241.24

352.40

ng/l

2.27

824

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1093

0.89

0.55

1.1

1.0

241.24

352.40

ng/l

2.27

824

Malignant neoplasm of ovary

160

0.69

0.55

1.0

326.50

366.47

ng/l

—

105

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.62

0.55

1.2

1.0

266.67

294.59

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

248

1.25

0.55

1.0

375.12

316.27

ng/l

0.34

170

Dermatophytosis

439

0.82

0.55

1.0

245.57

310.97

ng/l

1.38

316

Pregnancy hypertension

853

0.88

0.55

1.1

1.0

767.81

318.09

ng/l

0.57

650

Preparatory care for dialysis

125

0.64

0.54

1.1

1.0

413.75

318.12

ng/l

—

Congenital malformations of heart and great arteries

275

0.77

0.53

1.0

249.41

304.52

ng/l

0.88

195

Inflammatory bowel disease, strict (require KELA)

543

1.16

0.53

1.0

310.31

309.57

ng/l

0.01

411

Pedal cyclist injured in transport accident

571

1.16

0.53

1.0

273.58

315.94

ng/l

0.90

416

Other infective otitis externa

169

1.30

0.53

1.0

268.12

304.25

ng/l

0.46

109

Divergent concomitant strabismus

169

1.30

0.53

1.0

291.43

294.99

ng/l

0.02

117

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.45

0.53

1.0

331.89

254.08

ng/l

—

HSIL lesion of the cervix uteri, vagina or vulva

283

0.78

0.53

1.0

270.81

327.96

ng/l

0.95

218

Lymphoid leukaemia

158

0.69

0.52

1.2

1.0

242.40

306.08

ng/l

—

100

Deep endometriosis

187

1.29

0.52

1.0

378.31

327.39

ng/l

0.31

127

Spirochaetal infections, other/unspecified, including avohilmo

125

1129

1.11

0.52

1.0

287.18

329.42

ng/l

1.43

827

Separation of retinal layers (serosa)

117

1.37

0.52

1.1

1.0

223.10

263.89

ng/l

—

Non-allergic asthma (mode), excluding more controls

567

1.15

0.52

1.0

293.45

360.02

ng/l

1.29

390

Cholecystectomy

235

2145

0.93

0.52

1.0

316.50

345.64

ng/l

0.60

157

1565

Non-Hodgkin lymphoma, all, including Hilmo

501

0.84

0.52

1.0

411.76

330.80

ng/l

0.71

331

Deforming dorsopathies

788

1.13

0.52

1.0

264.84

377.91

ng/l

1.68

590

Disturbances of skin sensation

732

1.13

0.52

1.0

248.45

314.94

ng/l

2.67

537

Other congenital malformations, including avohilmo

250

1.24

0.52

1.0

245.08

308.79

ng/l

1.40

173

Other aneurysm

169

0.71

0.52

1.0

226.00

302.85

ng/l

—

110

Hypertrophy of tongue papillae

1.51

0.51

1.0

283.33

282.44

ng/l

—

Asthma-related pneumonia

124

1117

1.11

0.51

1.0

289.84

334.37

ng/l

1.49

778

Cervical polyps

270

0.78

0.51

1.0

253.12

344.40

ng/l

1.81

199

Other predominantly sexually transmitted diseases, not elsewhere classified

260

1.23

0.51

1.0

306.27

293.90

ng/l

0.15

198

Endometriosis ASRM stages 3,4

490

1.16

0.50

1.0

353.95

347.49

ng/l

0.05

355

Gout, FINNGEN

1067

0.89

0.50

1.0

278.85

319.63

ng/l

1.16

746

Outcome of delivery

111

0.72

0.50

1.0

208.69

265.96

ng/l

0.83

Glucosamine medication

196

1445

1.08

0.50

1.0

340.51

346.87

ng/l

0.09

139

1011

Spondyloarthritis

444

1.17

0.50

1.0

271.30

314.80

ng/l

0.96

328

Asthma, hospital admissions 3, pneumonia

124

1119

1.10

0.50

1.0

289.84

334.37

ng/l

1.49

778

Asthma-related pneumonia or sepsis

124

1119

1.10

0.50

1.0

289.84

334.37

ng/l

1.49

778

Seborrhoeic dermatitis

291

0.79

0.49

1.0

247.94

304.78

ng/l

0.80

207

Other spirochaetal diseases, including avohilmo

126

1143

1.10

0.49

1.0

290.27

328.02

ng/l

1.21

837

Gestational diabetes (for exclusion)

314

0.83

0.49

1.0

252.45

305.56

ng/l

1.38

257

Gonarthrosis [arthrosis of knee](FG)

317

1713

1.06

0.49

1.0

303.56

339.91

ng/l

0.78

230

1261

Panniculitis affecting regions of neck and back

1.43

0.49

1.1

1.0

202.83

320.78

ng/l

—

Phlebitis and thrombophlebitis (not including DVT)

712

0.87

0.49

1.0

297.63

316.25

ng/l

0.27

526

Vitamin B12 deficiency anaemia

298

1.21

0.49

1.1

1.0

253.79

313.84

ng/l

0.96

194

Adjustment and management of implanted device

572

0.86

0.48

1.0

303.12

338.70

ng/l

0.88

369

Ischemic heart diseases

349

1960

1.06

0.48

1.0

291.24

342.08

ng/l

1.61

248

1463

Congenital malformations, deformations and chromosomal abnormalities

164

1430

1.09

0.48

1.0

299.92

328.72

ng/l

0.44

125

1065

Superficial injury of shoulder and upper arm

308

1.20

0.48

1.0

260.38

304.83

ng/l

0.54

218

Benign neoplasm: Skin of upper limb, including shoulder

1.49

0.47

1.0

327.43

262.19

ng/l

—

Injury of muscle and tendon at lower leg level

474

0.84

0.47

1.0

258.31

312.18

ng/l

1.32

348

Ischaemic heart disease, wide definition

340

1974

1.06

0.47

1.0

296.14

349.33

ng/l

1.59

248

1456

IBD patients in KELA-register

550

1.15

0.47

1.0

310.31

310.09

ng/l

0.00

411

Certain disorders involving the immune mechanism

541

1.15

0.47

1.0

283.85

317.34

ng/l

0.79

390

Obesity and other hyperalimentation

191

1933

0.93

0.46

1.0

246.42

331.36

ng/l

3.55

146

1430

Other diseases of lip and oral mucosa

155

1426

1.09

0.46

1.0

326.97

340.33

ng/l

0.17

119

1046

Other disorders of optic [2nd] nerve and visual pathways

164

1.28

0.46

1.0

293.27

294.36

ng/l

0.01

107

Delivery

112

532

1.11

0.46

1.0

314.60

346.06

ng/l

0.50

371

DVT of lower extremities and pulmonary embolism

132

1437

0.91

0.46

1.0

297.10

326.21

ng/l

0.76

1011

Herpesviral [herpes simplex] infections

299

0.80

0.46

1.0

248.12

327.96

ng/l

1.43

216

GI-bleeding

114

1034

1.10

0.46

1.0

294.90

328.01

ng/l

0.98

726

Other sexually transmitted chlamydial diseases, including avohilmo

1.43

0.46

1.0

230.43

223.33

ng/l

—

Other joint disorders

278

1360

1.07

0.45

1.0

307.22

318.37

ng/l

0.26

205

1002

Benign neoplasm of eye and adnexa

331

0.81

0.45

1.0

332.16

316.42

ng/l

0.13

221

Asthma/COPD (KELA code 203)

340

2147

1.06

0.45

1.0

290.96

343.56

ng/l

1.68

248

1565

Adrenocortical insufficiency

0.59

0.45

1.0

350.00

298.11

ng/l

—

Benign neoplasm: Colon, unspecified

918

0.89

0.45

1.0

325.29

334.72

ng/l

0.12

649

Nonsuppurative otitis media

344

0.83

0.45

1.0

338.32

314.49

ng/l

0.19

237

Retinal breaks without detachment

552

1.14

0.45

1.0

346.63

312.44

ng/l

0.48

391

Diabetic retinopathy

117

658

1.10

0.45

1.0

260.91

292.91

ng/l

0.99

485

Cholelithiasis

292

2114

0.94

0.45

1.0

306.14

344.37

ng/l

0.97

201

1548

Heartburn

310

1.19

0.45

1.1

1.0

251.34

320.59

ng/l

2.08

220

All dysplastic lesions of the cervix uteri, vagina or vulva

502

0.85

0.45

1.0

250.61

394.61

ng/l

1.34

383

Acute upper respiratory infections of multiple and unspecified sites

228

1777

0.93

0.45

1.0

274.53

333.41

ng/l

1.62

174

1294

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

174

1.27

0.45

1.0

269.85

325.36

ng/l

0.79

121

Retinal vascular occlusion

366

1.18

0.45

1.0

276.10

309.72

ng/l

0.49

236

Primary_lymphoid and hematopoietic malignant neoplasms

822

0.89

0.45

1.1

1.0

367.06

323.07

ng/l

0.50

577

ILD medications: azathioprine

366

1.18

0.44

1.0

358.09

322.71

ng/l

0.27

263

Overexertion and strenuous or repetitive movements

265

1.21

0.44

1.0

235.78

309.08

ng/l

1.70

184

Disorders of mineral metabolism

247

1.22

0.44

1.0

343.95

337.74

ng/l

0.04

165

Nutritional anaemias

177

1565

1.08

0.44

1.0

306.76

335.31

ng/l

0.72

129

1089

Hypertrophy of breast

404

1.16

0.44

1.0

310.65

340.28

ng/l

0.33

301

Other systemic involvement of connective tissue (FG)

826

0.89

0.44

1.0

349.20

345.74

ng/l

0.04

568

Familial hypercholesterolemia

507

1.15

0.43

1.0

278.45

349.17

ng/l

1.51

333

Idiopathic gout

318

0.82

0.43

1.0

287.16

318.65

ng/l

0.44

218

Migraine, single triptan purchase ok & required. ICD-code if available is included

243

1543

1.07

0.43

1.0

277.70

337.26

ng/l

1.57

184

1160

Triptan medication for migraine, single purchase ok

243

1543

1.07

0.43

1.0

277.70

337.26

ng/l

1.57

184

1160

Internal derangement of knee

135

1228

1.09

0.43

1.0

275.18

309.58

ng/l

1.12

105

909

Other (seronegative) rheumatoid arthritis, wide

554

0.87

0.43

1.0

369.09

330.60

ng/l

0.44

390

Lyme disease

123

1126

1.09

0.42

1.0

285.15

329.69

ng/l

1.53

825

Lyme disease, including avohilmo

123

1126

1.09

0.42

1.0

285.15

329.69

ng/l

1.53

825

Acute bronchitis

109

1173

0.91

0.42

1.0

247.56

331.21

ng/l

4.27

833

Postprocedural endocrine and metabolic disorders, not elsewhere classified

294

1.19

0.42

1.0

236.89

357.36

ng/l

2.80

203

Scar conditions and fibrosis of skin

0.64

0.42

1.0

371.17

287.67

ng/l

—

Alcoholic gastritis

1.57

0.42

1.2

1.0

303.60

282.40

ng/l

—

Single spontaneous delivery

111

532

1.10

0.42

1.0

314.17

346.06

ng/l

0.50

371

Laparoscopic right hemicolectomy

184

0.76

0.41

1.0

481.22

305.67

ng/l

—

120

Benign neoplasm: Ciliary body

0.00

0.41

0.0

1.1

—

262.89

—

Acute laryngitis and tracheitis

159

0.74

0.41

1.0

518.14

290.22

ng/l

—

116

Fitting and adjustment of external prosthetic device

0.00

0.41

0.0

1.0

—

323.00

—

Other cestode infections

0.00

0.41

0.0

1.1

—

335.89

—

Malignant neoplasm of ovary, including Hilmo

195

0.77

0.41

1.0

299.00

370.30

ng/l

—

130

Medical abortion

161

941

0.93

0.41

1.0

388.88

380.26

ng/l

0.06

116

689

Nezelof syndrome

0.00

0.41

0.0

1.1

—

258.00

—

Maltreatment syndromes

1.38

0.41

1.1

1.0

366.50

238.48

ng/l

—

Congenital cataract

0.00

0.41

0.0

1.1

—

315.30

—

Benign neoplasm: Retina

0.00

0.41

0.0

1.0

—

317.67

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.41

0.0

1.1

—

294.00

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

332

1.18

0.41

1.0

259.97

343.48

ng/l

1.91

241

Reiter disease

0.00

0.41

0.0

1.0

—

301.13

—

Other protozoal intestinal diseases

1.52

0.41

1.2

1.0

401.00

250.19

ng/l

—

Lichen planopilaris

0.00

0.41

0.0

1.0

—

313.27

—

Granuloma annulare

1.52

0.41

1.0

195.60

337.04

ng/l

—

Other cestode infections, including avohilmo

0.00

0.41

0.0

1.1

—

335.89

—

Left side

0.00

0.41

0.0

1.0

—

281.91

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

0.41

0.0

1.0

—

368.25

—

Benign neoplasm of breast

294

0.82

0.41

1.0

853.37

354.26

ng/l

0.51

211

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.41

0.0

1.1

—

242.90

—

Malignant neoplasm of uterus, part unspecified, including Hilmo

0.00

0.41

0.0

1.1

—

405.09

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.41

0.0

1.0

—

264.78

—

Melanocytic naevi of ear and external auricular canal

0.00

0.41

0.0

1.1

—

287.10

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.41

0.0

1.1

—

348.00

—

Malignant neoplasm of penis, including Hilmo

0.00

0.41

0.0

1.0

—

224.91

—

Acute inflammation of orbit

0.00

0.41

0.0

1.0

—

269.63

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.41

0.0

1.0

—

250.64

—

Infections with a predominantly sexual mode of transmission

565

1.13

0.41

1.0

274.12

322.40

ng/l

1.28

415

Cholelithiasis, broad definition with cholecystitis

306

2148

0.95

0.41

1.0

308.19

344.58

ng/l

0.93

207

1571

Rheumatoid lung disease

0.00

0.41

0.0

1.1

—

292.50

—

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

370.44

—

Malignant neoplasm of gum

0.00

0.41

0.0

1.1

—

304.30

—

ILD medications: nintedanib

0.00

0.41

0.0

1.1

—

268.90

—

Hydrocephalus in other diseases

0.00

0.41

0.0

1.0

—

303.58

—

Acute myringitis

0.00

0.41

0.0

1.1

—

279.55

—

AV-block

616

0.89

0.41

1.0

268.27

346.92

ng/l

2.69

403

Other and unspecified acne

0.00

0.40

0.0

1.0

—

260.80

—

Abnormal serum enzyme levels

125

1108

1.09

0.40

1.0

321.17

313.87

ng/l

0.12

790

Paralytic ileus and intestinal obstruction

842

1.10

0.40

1.0

283.92

338.86

ng/l

1.93

590

Disorders of calcium metabolism

186

1.24

0.40

1.0

390.41

335.18

ng/l

0.34

119

Malignant neoplasm of vagina, including Hilmo

0.00

0.40

0.0

1.1

—

420.60

—

Obesity

191

1921

0.94

0.40

1.0

246.42

331.43

ng/l

3.53

146

1421

Spontaneous abortion

112

820

0.91

0.40

1.0

302.56

367.70

ng/l

0.75

618

0.00

0.40

0.0

1.1

—

288.62

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.40

0.0

1.1

—

262.67

—

Dermatopolymyositis, unspecified

0.00

0.40

0.0

1.1

—

286.64

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.40

0.0

1.1

—

288.62

—

Chromophobe cell carcinoma of kidney

0.00

0.40

0.0

1.1

—

257.17

—

Toxoplasmosis

0.00

0.40

0.0

1.1

—

279.10

—

Toxoplasmosis, including avohilmo

0.00

0.40

0.0

1.1

—

279.10

—

Arthropathies

285

1360

1.06

0.40

1.0

302.42

318.37

ng/l

0.42

214

1002

Drug-induced systemic lupus erythematosus

0.00

0.40

0.0

1.1

—

356.36

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.40

0.0

1.0

—

270.91

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.40

0.0

1.0

—

309.40

—

Visual field defects

249

0.80

0.40

1.1

1.0

700.93

301.38

ng/l

0.59

173

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.40

0.0

1.0

—

223.08

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.40

0.0

1.1

—

270.42

—

Other diseases of pericardium

149

0.74

0.40

1.0

207.00

289.96

ng/l

—

Combinations of oral blood glucose lowering drugs

115

1054

1.09

0.40

1.1

1.0

281.55

328.62

ng/l

0.81

763

Other complications of surgical and medical care, not elsewhere classified

278

1.19

0.39

1.0

332.54

322.69

ng/l

0.07

189

Retinal vascular disorders

371

1.16

0.39

1.0

276.10

309.68

ng/l

0.49

240

Azathioprine

371

1.16

0.39

1.0

358.09

318.71

ng/l

0.31

271

Lichen planus, including avohilmo

616

1.12

0.39

1.0

300.70

334.57

ng/l

0.52

442

Cauda equina syndrome

1.43

0.39

1.0

319.00

254.95

ng/l

—

Bacterial intestinal infections, IBD co-morbidities

531

1.13

0.39

1.0

300.30

325.62

ng/l

0.43

367

Carcinoma in situ of endometrium

0.00

0.39

0.0

1.1

—

308.77

—

Paget disease

0.00

0.39

0.0

1.0

—

320.60

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.39

0.0

1.0

—

380.23

—

Purpura and other haemorrhagic conditions

362

1.16

0.39

1.0

299.59

304.90

ng/l

0.05

246

Typhoid and paratyphoid fevers, including avohilmo

0.00

0.39

0.0

1.0

—

382.40

—

Other diseases of anus and rectum

109

994

1.09

0.39

1.0

292.85

341.48

ng/l

1.31

700

Benign neoplasm: Transverse colon

381

1.16

0.39

1.0

305.80

319.07

ng/l

0.11

267

Iron deficiency anaemia

147

1337

1.08

0.39

1.0

317.23

335.38

ng/l

0.34

108

928

5-aminosalicylic acid

541

1.13

0.39

1.0

309.08

320.51

ng/l

0.12

399

Other spirochaetal diseases

123

1133

1.09

0.38

1.0

285.15

329.43

ng/l

1.52

831

Other congenital malformations of skin, including avohilmo

169

1.24

0.38

1.0

276.13

294.17

ng/l

0.18

115

Other abnormal findings of blood chemistry

133

1.28

0.38

1.1

1.0

196.83

309.85

ng/l

1.67

Disorders of muscles

270

1.19

0.38

1.0

251.78

332.98

ng/l

2.20

194

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.33

0.37

1.1

1.0

240.71

310.15

ng/l

—

Artrosis, including avohilmo

296

1537

1.05

0.37

1.0

300.13

340.63

ng/l

0.80

212

1151

Rosacea

336

1.16

0.37

1.0

361.79

324.24

ng/l

0.25

240

Benign neoplasm: Adrenal gland

271

1.18

0.37

1.0

280.48

317.14

ng/l

0.46

185

Persons encountering health services in circumstances related to reproduction

170

1219

0.93

0.37

1.0

306.78

334.90

ng/l

0.36

132

945

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

505

1.13

0.37

1.1

1.0

239.38

319.90

ng/l

3.91

355

Inflammatory disease of cervix uteri

161

1.24

0.37

1.0

376.60

341.73

ng/l

0.25

110

Other/unspecified rheumatoid arthritis

365

0.85

0.37

1.0

323.26

329.83

ng/l

0.06

244

Prepatellar bursitis

134

1.27

0.37

1.0

261.42

327.96

ng/l

0.75

Complications predominantly related to the puerperium

515

1.13

0.37

1.1

1.0

298.02

399.04

ng/l

0.77

385

Other viral diseases, not elsewhere classified

410

1.14

0.36

1.0

291.67

307.72

ng/l

0.16

299

Diabetic retinopathy, strict definition

365

1.14

0.36

1.0

296.51

272.14

ng/l

0.31

274

Misadventures to patients during surgical and medical care

412

1.14

0.36

1.0

958.47

325.62

ng/l

0.45

286

Benign neoplasm of major salivary glands

310

0.84

0.36

1.1

1.0

304.56

317.09

ng/l

0.09

216

Secondary uncertain malignant neoplasm

481

0.87

0.36

1.0

354.24

336.02

ng/l

0.16

320

Acne

1.26

0.36

1.1

1.0

203.89

226.16

ng/l

—

Morphin

0.66

0.36

1.4

1.0

329.80

358.15

ng/l

—

Coagulation defects, purpura and other haemorrhagic conditions

526

1.12

0.35

1.0

302.39

322.03

ng/l

0.23

369

Rheumatoid arthritis

102

982

0.92

0.35

1.0

346.09

337.02

ng/l

0.12

706

Non-allergic asthma

217

1.20

0.35

1.0

335.95

327.71

ng/l

0.05

143

Other disorders of breast

310

1.16

0.35

1.1

1.0

280.86

341.09

ng/l

0.76

226

Acute appendicitis

213

2091

0.94

0.35

1.0

278.66

327.63

ng/l

1.56

169

1555

Complications of labour and delivery

164

974

0.93

0.35

1.0

461.48

353.82

ng/l

0.61

122

718

Pregnancy, childbirth and the puerperium

323

1.12

0.35

1.0

351.53

314.02

ng/l

0.43

212

Non-Hodgkin lymphoma, all

134

0.74

0.35

1.0

342.20

339.31

ng/l

—

Other heart diseases, wide

327

1888

1.05

0.34

1.0

293.25

336.85

ng/l

1.22

250

1398

Infections of the skin and subcutaneous tissue

191

1770

1.06

0.34

1.0

277.25

330.66

ng/l

1.38

145

1303

Nonsuppurative otitis media, including avohilmo

533

0.89

0.34

1.0

299.69

316.91

ng/l

0.21

383

L02BA Anti-estrogens

447

0.87

0.34

1.1

1.0

295.87

350.94

ng/l

1.07

316

Other necrotizing vasculopathies

218

1.19

0.34

1.0

364.53

317.52

ng/l

0.47

144

Disorders of vitreous body

213

1915

1.06

0.34

1.0

378.15

344.18

ng/l

0.23

158

1393

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

283

1.17

0.34

1.0

299.48

289.12

ng/l

0.12

213

Codeine or tramadol medication

401

2088

1.04

0.34

1.0

355.19

334.55

ng/l

0.09

297

1512

Delivery, wide proxy

390

1.10

0.33

1.0

334.72

333.87

ng/l

0.01

257

Benign neoplasm: Rectum

643

1.11

0.33

1.0

326.14

327.54

ng/l

0.02

447

Other and unspecified rosacea

237

1.18

0.33

1.0

404.68

319.88

ng/l

0.53

167

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

136

1.25

0.33

1.0

270.50

269.48

ng/l

0.01

Acute appendicitis, with complications

594

0.89

0.33

1.1

1.0

308.76

318.70

ng/l

0.10

426

Other and unspecified iron deficiency

113

1044

1.08

0.33

1.0

304.29

336.03

ng/l

0.65

724

Other viral diseases

622

1.11

0.33

1.0

303.85

306.66

ng/l

0.03

465

Crohn disease

312

1.15

0.33

1.0

334.54

311.23

ng/l

0.16

228

Use of rasagiline

0.68

0.33

1.2

1.0

242.33

314.72

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

403

0.87

0.33

1.0

337.20

322.52

ng/l

0.13

286

Scabies, including avohilmo

284

1.16

0.33

1.1

1.0

330.77

293.05

ng/l

0.35

204

Chondropathies

378

1.14

0.33

1.0

281.92

320.21

ng/l

0.85

279

Benign lipomatous neoplasm

103

951

1.08

0.33

1.0

325.15

323.31

ng/l

0.02

690

Thiazolidinediones

397

1.13

0.33

1.1

1.0

242.12

337.23

ng/l

3.13

274

Effects of foreign body entering through natural orifice

692

1.10

0.32

1.0

324.38

300.97

ng/l

0.22

511

Trochanteric bursitis

454

1.12

0.32

1.0

321.47

352.49

ng/l

0.28

324

Diseases of the digestive system

160

1491

1.07

0.32

1.0

323.17

331.00

ng/l

0.12

117

1054

Endometriosis of ovary

399

0.87

0.32

1.0

335.15

374.90

ng/l

0.29

286

Unspecified event, undetermined intent

1.28

0.32

1.0

239.67

280.39

ng/l

—

Disorders of vitreous body and globe

218

1954

1.05

0.32

1.0

377.52

343.21

ng/l

0.24

159

1420

Chronic pancreatitis

423

0.87

0.32

1.0

197.68

317.16

ng/l

5.62

315

Benign neoplasm of urinary organs

137

1.24

0.32

1.0

325.08

301.03

ng/l

0.17

Noninfectious colitis NAS

351

1.14

0.31

1.0

237.59

322.69

ng/l

3.65

248

Arthropod-borne viral fevers and viral haemorrhagic fevers

284

0.84

0.31

1.1

1.0

225.89

307.49

ng/l

2.15

200

Zoster [herpes zoster], including avohilmo

181

1848

0.94

0.31

1.0

284.36

358.22

ng/l

2.03

132

1323

Menorrhagia

487

1.09

0.31

1.1

1.0

721.86

372.82

ng/l

0.47

350

Normotensive glaucoma

286

1.16

0.31

1.0

523.23

307.89

ng/l

0.60

191

Vitreous haemorrhage

315

0.86

0.30

1.0

306.82

308.14

ng/l

0.01

222

Other diseases of intestine

523

1.11

0.30

1.1

1.0

289.69

331.29

ng/l

0.67

381

Gonarthrosis,primary

380

2203

1.04

0.30

1.0

314.38

337.94

ng/l

0.55

272

1621

Conductive hearing loss, unspecified

212

1.18

0.30

1.0

258.53

295.79

ng/l

0.49

151

Seronegative rheumatoid arthritis

357

0.87

0.30

1.0

361.83

330.03

ng/l

0.24

254

Necrosis of pulp, including avohilmo

194

1817

1.05

0.30

1.0

352.26

317.92

ng/l

0.38

155

1364

Other and unspecified disorders of vitreous body

182

1685

1.06

0.29

1.0

389.18

346.22

ng/l

0.26

136

1215

Erysipelas

219

1796

1.05

0.29

1.0

280.51

327.22

ng/l

2.16

147

1301

Pacemaker

135

1177

1.07

0.29

1.0

297.18

342.63

ng/l

1.55

101

798

Other and unspecified dermatitis

187

1773

1.05

0.29

1.0

271.33

349.58

ng/l

2.38

131

1285

Dental pulpitis, including avohilmo

314

1928

1.04

0.29

1.0

300.28

325.26

ng/l

0.40

243

1448

Squamous cell neoplasms and carcinomas of the skin

345

0.87

0.29

1.0

289.47

344.31

ng/l

0.50

216

Soft tissue disorders related to use, overuse and pressure

102

948

1.08

0.29

1.0

289.52

361.58

ng/l

0.94

686

Other otitis externa (chronic)

185

1.19

0.29

1.0

208.69

310.76

ng/l

2.78

124

Oral corticosteroids

381

2150

1.04

0.29

1.0

324.33

334.34

ng/l

0.14

282

1571

Injury of eye and orbit

335

1.14

0.29

1.0

281.17

313.54

ng/l

0.52

241

Other abnormal uterine and vaginal bleeding

452

1.10

0.29

1.0

281.98

376.62

ng/l

1.91

319

Polyp of the female genital tract

487

0.92

0.29

1.1

1.0

291.56

372.82

ng/l

1.56

350

Conjunctivitis (acute, non atopic), including avohilmo

344

2158

0.96

0.28

1.0

296.66

339.24

ng/l

1.25

256

1578

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

449

1.11

0.28

1.1

1.0

244.51

324.05

ng/l

3.50

319

Cholesteatoma of middle ear

140

0.78

0.28

1.1

1.0

240.00

311.48

ng/l

—

Glaucoma, exfoliation

312

0.86

0.28

1.1

1.0

380.43

308.24

ng/l

0.59

205

Other systemic involvement of connective tissue

825

0.92

0.28

1.0

346.82

337.24

ng/l

0.12

576

Mycoses

856

0.92

0.28

1.1

1.0

279.61

330.85

ng/l

1.65

608

Contraceptive management

109

815

0.93

0.27

1.0

310.64

337.54

ng/l

0.24

654

Systemic connective tissue disorders

103

1103

0.93

0.27

1.0

353.36

329.50

ng/l

0.45

761

Carcinoma in situ of breast, intraductal

258

0.85

0.27

1.0

395.35

359.85

ng/l

0.21

182

Acute pancreatitis (for exclusion)

657

0.91

0.27

1.0

312.13

320.09

ng/l

0.10

470

414

2027

1.03

0.26

1.1

1.0

291.58

353.48

ng/l

2.08

298

1473

Presbycusis

380

1.12

0.26

1.0

299.40

329.32

ng/l

0.40

234

Idiopathic thrombocytopenic purpura

1.21

0.26

1.0

237.13

263.88

ng/l

—

Contact with machinery

347

1.12

0.26

1.0

288.63

285.81

ng/l

0.03

255

Other disorders of pigmentation

113

1.24

0.26

1.0

515.13

295.27

ng/l

—

Nonalcoholic fatty liver disease

289

0.86

0.26

1.0

219.65

310.25

ng/l

1.38

211

Other disorders of kidney and ureter

414

1.11

0.26

1.0

298.27

320.06

ng/l

0.27

287

Endometriosis of pelvic peritoneum

333

1.12

0.26

1.0

339.35

347.09

ng/l

0.06

250

Reactive arthropathies

225

1.16

0.26

1.1

1.0

296.05

327.26

ng/l

0.27

167

Abrasion of teeth

130

1226

1.06

0.26

1.0

289.54

345.74

ng/l

0.97

100

906

Other and unspecified diseases of blood and blood-forming organs

0.67

0.26

1.0

197.80

300.06

ng/l

—

Other lesions of median nerve

0.67

0.26

1.0

488.60

285.28

ng/l

—

Acute peritonitis

169

1.18

0.25

1.0

245.30

297.67

ng/l

—

111

Diabetic nephropathy, excluding more controls

314

1.12

0.25

1.0

350.06

286.09

ng/l

0.86

229

Hallux valgus (acquired)

127

855

1.06

0.25

1.0

341.06

344.95

ng/l

0.05

619

Other noninflammatory disorders of uterus, except cervix

465

0.92

0.25

1.0

348.49

377.19

ng/l

0.32

331

Ulcerative rectosigmoiditis

207

1.16

0.25

1.0

298.79

299.00

ng/l

0.00

148

Other nutritional deficiencies

210

2002

0.96

0.24

1.0

246.68

332.54

ng/l

3.91

160

1478

Oral lichen planus, including avohilmo , including avohilmo

217

1.15

0.24

1.0

409.25

317.33

ng/l

0.52

159

Artificial joint operation, meniscal resection

368

2276

1.03

0.24

1.0

328.76

335.16

ng/l

0.11

268

1667

Melanocytic naevi of trunk

328

0.88

0.23

1.0

249.48

311.28

ng/l

1.65

231

Hepatic failure, not elsewhere classified

106

1.23

0.23

1.0

524.00

293.53

ng/l

—

Heart failure, not strict

297

2066

0.97

0.23

1.0

294.81

348.38

ng/l

1.57

232

1505

Undetermined asthma, excluding more controls

370

1.11

0.23

1.0

324.21

366.89

ng/l

0.39

256

Injury of unspecified body region

190

1.16

0.23

1.0

300.13

295.21

ng/l

0.04

128

Follicular cysts of skin and subcutaneous tissue

524

1.09

0.23

1.0

302.80

316.81

ng/l

0.12

382

Other sexually transmitted chlamydial diseases

1.28

0.23

1.0

188.40

220.81

ng/l

—

Other peripheral vascular diseases

228

1.14

0.22

1.0

378.55

299.30

ng/l

0.53

148

Effects of other external causes

1.25

0.22

1.0

274.40

239.30

ng/l

—

Calcific tendinitis of shoulder

153

1.18

0.22

1.0

326.08

335.25

ng/l

0.09

107

Bacterial pneumonia (organism specified)

138

1313

0.95

0.22

1.0

250.83

338.90

ng/l

6.39

109

926

Respiratory tuberculosis, confirmed

1.22

0.22

1.0

211.20

275.19

ng/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

284

0.88

0.22

1.1

1.0

313.24

311.72

ng/l

0.01

199

Asthma and opportunity respiratory infection

135

0.81

0.22

1.0

306.00

322.41

ng/l

—

Esophageal diverticulum (pouch)

0.00

0.21

0.0

1.0

—

284.00

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

300.67

—

Hypertension, portal

0.00

0.21

0.0

1.0

—

308.80

—

Melanoma in situ, other sites/unspecified

0.00

0.21

0.0

1.0

—

314.67

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.21

0.0

1.1

—

242.60

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

267.60

—

Hereditary sideroblastic anaemia

0.00

0.21

0.0

1.0

—

281.40

—

Lupus nephritis

0.00

0.21

0.0

1.0

—

251.00

—

Respiratory tuberculosis, confirmed, including avohilmo

1.19

0.21

1.0

211.20

279.33

ng/l

—

Injury of blood vessels at abdomen, lower back and pelvis level

0.00

0.21

0.0

1.0

—

336.83

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.21

0.0

1.0

—

340.67

—

Injury of urinary and pelvic organs

1.19

0.21

1.0

242.40

258.22

ng/l

—

Injury of nerves and spinal cord at thorax level

0.00

0.21

0.0

1.0

—

377.80

—

Acute appendicitis, no complications

160

1663

0.96

0.21

1.0

268.71

323.74

ng/l

1.52

127

1252

Other congenital malformations of urinary system

0.00

0.21

0.0

1.0

—

311.17

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.21

0.0

1.0

—

295.83

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.21

0.0

1.0

—

244.60

—

Other specified transport accidents

0.00

0.21

0.0

1.0

—

305.80

—

Ulcerative proctitis

135

1.19

0.21

1.0

223.36

273.24

ng/l

0.71

Other nonautoimmune haemolytic anaemias

0.00

0.21

0.0

1.0

—

329.17

—

Pre-eclampsia

409

0.90

0.21

1.1

1.0

1345.93

340.81

ng/l

0.52

308

Dyspnoea

332

2321

1.03

0.21

1.0

383.69

326.60

ng/l

0.23

243

1696

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.21

0.0

1.0

—

317.86

—

Malignant neoplasm of meninges, including Hilmo

0.00

0.21

0.0

1.1

—

291.83

—

Other infective (teno)synovitis

0.00

0.21

0.0

1.1

—

244.17

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

250.83

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

265.57

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.0

—

368.14

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.0

—

238.29

—

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

328.00

—

Conotruncal defects

0.00

0.21

0.0

1.0

—

358.71

—

Diseases of peritoneum

296

1.12

0.21

1.0

299.24

314.07

ng/l

0.12

204

Puerperal sepsis

346

0.90

0.21

1.1

1.0

307.40

352.09

ng/l

0.56

254

Other disorders of adrenal gland

103

0.78

0.21

1.0

289.88

307.06

ng/l

—

Panhypopituitarism

1.16

0.21

1.0

299.80

268.41

ng/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.16

0.21

1.0

211.20

280.46

ng/l

—

Postmenopausal bleeding

480

0.94

0.21

1.0

291.41

374.69

ng/l

1.55

345

Other superficial mycoses

1.16

0.21

1.0

301.60

262.34

ng/l

—

Other ulcerative colitis

126

1.19

0.21

1.0

307.60

257.83

ng/l

—

Haemorrhoids and perianal venous thrombosis

123

1160

1.05

0.21

1.0

324.51

373.09

ng/l

0.57

813

Femoral hernia, bilateral

0.00

0.21

0.0

1.0

—

406.57

—

Toxic colitis

0.00

0.21

0.0

1.0

—

321.14

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

0.21

0.0

1.0

—

274.13

—

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

0.21

0.0

1.0

—

245.00

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

315.88

—

Other superficial injuries of ankle and foot

0.00

0.21

0.0

1.0

—

318.71

—

Clubfoot

0.00

0.21

0.0

1.1

—

290.63

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

421

1.09

0.21

1.0

327.40

307.15

ng/l

0.17

317

Postprocedural musculoskeletal disorders, not elsewhere classified

230

1.13

0.20

1.1

1.0

332.86

312.81

ng/l

0.09

149

Benign leiomyoma with endometriosis

431

1.09

0.20

1.0

356.78

347.21

ng/l

0.07

304

Inflammatory bowel disease treatment related agents

399

2151

1.03

0.20

1.0

289.73

334.25

ng/l

1.44

297

1572

Abnormal findings in peritoneal fluid saliva

0.00

0.20

0.0

1.0

—

274.44

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.20

0.0

1.0

—

285.13

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

0.20

0.0

1.0

—

273.00

—

Listeriosis

0.00

0.20

0.0

1.1

—

275.00

—

Other dermatomyositis

0.00

0.20

0.0

1.0

—

318.25

—

Listeriosis, including avohilmo

0.00

0.20

0.0

1.1

—

275.00

—

Other/unspecified mastoiditis and related conditions

0.00

0.20

0.0

1.0

—

310.83

—

Burn and corrosion, body region unspecified

0.00

0.20

0.0

1.0

—

278.00

—

Trigger finger

441

1.09

0.20

1.0

277.53

342.59

ng/l

1.27

321

Cholecystitis

428

0.91

0.20

1.1

1.0

313.71

329.38

ng/l

0.19

304

Leiomyoma of uterus

196

1056

1.04

0.20

1.0

541.55

339.32

ng/l

0.59

148

775

Fracture of foot, except ankle

635

1.07

0.20

1.1

1.0

299.13

325.18

ng/l

0.38

474

Corneal degeneration

1.20

0.19

1.0

326.33

277.50

ng/l

—

Salpingitis and oophoritis

500

0.92

0.19

1.0

311.52

415.65

ng/l

0.65

367

Dermatophytosis, including avohilmo

229

2166

1.04

0.19

1.0

279.79

330.10

ng/l

1.63

165

1597

LSIL lesion of the cervix uteri, vagina or vulva

231

1.13

0.19

1.0

263.22

335.34

ng/l

1.41

177

Bronchitis

368

2267

0.97

0.19

1.0

267.98

346.89

ng/l

3.72

271

1647

False labour

246

0.91

0.19

1.0

249.73

302.88

ng/l

0.80

208

Non-follicular lymphoma

312

0.90

0.19

1.0

343.43

316.84

ng/l

0.25

213

Benign neoplasm: Ascending colon

491

1.08

0.19

1.0

269.38

329.95

ng/l

1.48

344

Granulomatous disorders of skin and subcutaneous tissue

1.15

0.19

1.0

235.50

309.56

ng/l

—

Other superficial mycoses, including avohilmo

222

1.13

0.19

1.0

309.25

297.11

ng/l

0.11

151

Other specified/unspecified inflammatory spondylopathies

1.24

0.18

1.1

1.0

297.40

353.53

ng/l

—

Retained placenta and membranes, without haemorrhage

280

0.89

0.18

1.1

1.0

466.72

327.98

ng/l

1.18

207

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

207

1993

1.04

0.18

1.0

311.72

340.11

ng/l

0.49

151

1432

Ulcerative colitis

647

1.07

0.18

1.0

273.52

317.46

ng/l

1.13

473

Other obstetric conditions, not elsewhere classified

144

0.88

0.18

1.0

259.40

268.24

ng/l

0.06

125

Other arthritis (FG)

1022

0.95

0.18

1.0

364.75

351.38

ng/l

0.06

733

Acute pancreatitis

642

0.93

0.18

1.0

312.13

320.03

ng/l

0.10

475

Other septicaemia

135

1218

1.04

0.18

1.0

299.72

343.91

ng/l

1.18

854

ILD medications

377

2084

0.97

0.18

1.0

292.46

336.06

ng/l

1.34

280

1526

Undetermined asthma

376

1.09

0.18

1.0

324.21

363.98

ng/l

0.36

260

Bronchiectasis

269

0.89

0.18

1.0

375.11

317.83

ng/l

0.37

175

Vasomotor rhinitis (mode)

204

1.13

0.18

1.0

252.36

303.80

ng/l

0.76

142

Varicose veins of other sites

185

1.14

0.18

1.0

878.07

296.18

ng/l

0.41

134

Long labour

316

0.91

0.17

1.0

386.83

300.41

ng/l

1.21

251

Entropion and trichiasis of eyelid

258

0.89

0.17

1.0

287.69

317.48

ng/l

0.23

166

Coeliac disease

300

1.10

0.17

1.0

321.85

315.11

ng/l

0.03

213

Artificial joint re-operation

237

0.89

0.17

1.0

379.73

316.66

ng/l

0.44

158

Nontoxic goitre/thyroid nodule

928

0.95

0.17

1.0

320.11

330.11

ng/l

0.12

646

Other acute lower respiratory infections

152

1505

0.96

0.17

1.0

241.19

323.16

ng/l

6.07

111

1071

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

852

1.05

0.17

1.0

286.56

308.27

ng/l

0.38

643

Obesity related asthma

122

1167

1.05

0.17

1.0

277.47

348.91

ng/l

1.27

846

Burn and corrosion of trunk

1.13

0.17

1.3

1.0

180.14

255.81

ng/l

—

Noninflammatory disorders of female genital tract

487

0.95

0.17

1.0

293.65

372.82

ng/l

1.67

350

Rash and other nonspecific skin eruption

247

0.89

0.17

1.0

338.65

320.78

ng/l

0.15

168

Nontoxic single thyroid nodule

205

0.88

0.17

1.0

315.85

345.67

ng/l

0.30

141

Ulcerative colitis, NAS

351

0.91

0.17

1.0

276.88

315.27

ng/l

0.58

259

Pedal cyclist injured in other and unspecified transport accidents

299

0.90

0.17

1.0

253.89

308.42

ng/l

0.74

210

Blepharochalasis

113

1080

1.05

0.17

1.0

313.17

364.66

ng/l

0.60

755

Anaemia in chronic diseases classified elsewhere

0.72

0.17

1.2

1.0

382.20

294.29

ng/l

—

Otalgia

205

1.12

0.17

1.0

248.72

293.48

ng/l

0.70

145

Dermatitis

222

2104

1.03

0.16

1.0

268.90

348.00

ng/l

3.14

156

1525

All chronic kidney diseases

185

1525

0.97

0.16

1.0

305.75

328.33

ng/l

0.61

143

1065

Otitis externa, unspecified

298

0.91

0.16

1.0

325.19

316.93

ng/l

0.05

210

Gout

864

0.95

0.16

1.0

278.85

317.04

ng/l

1.04

618

Short Achilles tendon (acquired)

1.13

0.16

1.3

1.0

321.13

314.85

ng/l

—

Other and unspecified anaemias

156

1411

1.04

0.16

1.0

329.40

340.70

ng/l

0.20

122

962

Other secondary coxarthrosis

1.20

0.16

1.0

694.36

299.95

ng/l

0.42

Other/unspecified synovitis and tenosynovitis

312

1.09

0.15

1.0

313.86

341.93

ng/l

0.28

226

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

129

780

1.04

0.15

1.0

299.30

334.74

ng/l

0.82

605

Unspecified misadventure during surgical and medical care

168

1.13

0.15

1.0

247.71

296.70

ng/l

0.62

109

Disorders of optic nerve and visual pathways

216

1.11

0.15

1.0

273.78

301.24

ng/l

0.29

146

Bullous disorders

159

1.13

0.15

1.1

1.0

262.00

308.38

ng/l

0.64

102

Decubitus ulcer and pressure area

159

1.13

0.15

1.1

1.0

383.18

299.15

ng/l

0.64

102

Benign thyroid growths and nodules

105

1018

0.96

0.15

1.0

306.53

393.26

ng/l

1.19

737

Benign neoplasm of ovary

478

1.07

0.15

1.0

299.49

354.12

ng/l

0.87

344

Injury of other and unspecified intrathoracic organs

188

1.12

0.14

1.0

271.50

316.01

ng/l

0.67

129

Nummular dermatitis

265

1.10

0.14

1.0

251.62

302.06

ng/l

0.96

184

Other specified/unspecified arthritis

891

0.95

0.14

1.0

371.91

329.86

ng/l

0.23

641

Cutaneous abscess, furuncle and carbuncle

717

0.95

0.14

1.0

247.66

311.11

ng/l

1.84

526

Vestibular neuronitis

275

1.09

0.14

1.0

260.89

322.84

ng/l

0.84

187

Disorders of tooth development and eruption

274

0.92

0.14

1.0

243.35

344.79

ng/l

2.44

200

Other maternal disorders predominantly related to pregnancy

146

945

0.97

0.14

1.1

1.0

293.78

368.12

ng/l

1.15

111

715

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

184

1626

1.03

0.14

1.0

301.54

326.23

ng/l

0.40

138

1207

Acute suppurative otitis media

347

1.07

0.14

1.1

1.0

266.41

299.94

ng/l

0.67

246

Fall on and from ladder

243

0.90

0.13

1.0

290.86

302.05

ng/l

0.06

168

Otitis externa

646

1.05

0.13

1.0

281.16

326.45

ng/l

0.91

467

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

220

2100

1.03

0.13

1.0

307.70

326.99

ng/l

0.42

162

1514

Other arrhythmias

236

1806

0.97

0.13

1.0

320.86

341.17

ng/l

0.37

172

1332

Iron deficiency anaemia secondary to blood loss (chronic)

479

0.94

0.13

1.0

354.53

331.38

ng/l

0.20

325

Other and unspecified injuries of lower leg

180

1.11

0.13

1.1

1.0

279.86

308.17

ng/l

0.20

120

Chalazion

296

1.08

0.13

1.1

1.0

334.88

317.74

ng/l

0.12

210

Benign neoplasm: Rectum, anus and anal canal

706

1.05

0.13

1.0

325.22

329.00

ng/l

0.05

491

Calculus of kidney and ureter

989

0.96

0.13

1.0

306.69

314.81

ng/l

0.11

716

Localized swelling, mass and lump of skin and subcutaneous tissue

101

1050

0.96

0.13

1.0

268.56

324.70

ng/l

1.82

762

Angina pectoris

235

1597

0.98

0.13

1.0

269.15

330.89

ng/l

4.47

174

1157

Other skin changes

662

0.95

0.12

1.0

335.76

327.60

ng/l

0.12

460

Other/unspecified enthesopathies of lower limb, excluding foot

171

1.11

0.12

1.0

249.38

336.56

ng/l

0.85

124

Female genital prolapse

485

1.04

0.12

1.0

288.50

373.42

ng/l

1.65

349

Other specified and unspecified disorders of eye and adnexa

1.18

0.12

1.0

404.30

298.30

ng/l

—

Vascular disorders of the intestines

200

1.10

0.12

1.0

233.30

306.47

ng/l

—

133

Benign neoplasm: Choroid

210

0.90

0.12

1.0

332.83

309.65

ng/l

0.13

140

Degeneration of macula and posterior pole

181

1434

0.97

0.12

1.0

316.36

347.80

ng/l

0.84

124

983

Bacterial pneumoniae

137

1166

1.03

0.11

1.0

250.91

341.81

ng/l

6.34

108

831

Neoplasms

224

1203

0.98

0.11

1.0

305.39

304.72

ng/l

0.01

169

866

Diseases of salivary glands

996

0.96

0.11

1.0

310.18

323.75

ng/l

0.23

722

Sequelae with surgical and medical care as external cause

640

1.05

0.11

1.0

270.85

327.46

ng/l

1.35

447

Other anaemias

156

1419

1.03

0.11

1.0

329.40

340.75

ng/l

0.20

122

969

Other benign neoplasms of skin

120

1239

0.97

0.11

1.0

327.15

327.81

ng/l

0.01

882

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

376

1.06

0.11

1.0

289.32

310.94

ng/l

0.34

281

Benign neoplasm: Small intestine

124

1.13

0.11

1.0

273.22

321.87

ng/l

—

Other vitreous opacities

124

1.13

0.11

1.0

276.22

292.33

ng/l

—

Sequelae of external causes of morbidity and mortality

798

1.04

0.11

1.0

270.61

325.40

ng/l

1.58

566

Sicca syndrome [Sjögren]

240

1.08

0.11

1.0

360.50

327.11

ng/l

0.23

166

Peritonsillar abscess

496

0.95

0.11

1.0

261.67

301.81

ng/l

0.94

373

Pruritus

291

0.93

0.11

1.0

401.59

334.17

ng/l

0.48

202

Major coronary heart disease event

348

2045

1.02

0.10

1.0

289.56

341.72

ng/l

1.76

243

1518

Presence of cardiac and vascular implants and grafts

169

1274

0.97

0.10

1.0

289.26

324.28

ng/l

1.11

130

887

Other blood glucose lowering drugs, excl. Insulins

534

1.05

0.10

1.0

332.70

341.07

ng/l

0.05

369

Mixed hyperlipidaemia

115

1.13

0.10

1.0

275.50

339.79

ng/l

—

Osteonecrosis

202

1.09

0.10

1.0

413.06

305.75

ng/l

0.54

135

Diabetes mellitus in pregnancy

224

0.94

0.10

1.0

253.08

299.16

ng/l

0.97

188

Disorders of gallbladder, biliary tract and pancreas

361

2282

0.98

0.10

1.0

293.84

338.33

ng/l

1.48

250

1684

Benign neoplasm: Caecum

372

0.94

0.10

1.1

1.0

286.21

321.29

ng/l

0.54

252

Intestinal stricture

102

1053

0.97

0.10

1.1

1.0

268.70

334.95

ng/l

3.13

751

Superficial injury of ankle and foot

259

0.93

0.10

1.1

1.0

254.18

317.90

ng/l

0.80

183

Ulcerative colitis (strict definition, all Crohn cases excluded)

339

1.06

0.10

1.0

276.37

312.48

ng/l

0.65

246

Melanoma in situ of other and unspecified parts of face

1.14

0.10

1.0

217.00

294.28

ng/l

—

Stomatitis and related lesions

524

0.95

0.09

1.0

291.95

318.97

ng/l

0.42

376

Coronary atherosclerosis

273

1752

0.98

0.09

1.0

290.19

348.94

ng/l

1.64

191

1282

Other septicaemia, including avohilmo

136

1243

1.03

0.09

1.0

300.62

342.33

ng/l

1.10

869

Malignant neoplasm of thyroid gland

203

1.08

0.09

1.0

292.35

357.43

ng/l

0.70

139

Diabetic maculopathy, excluding more controls

281

1.07

0.09

1.0

232.89

313.47

ng/l

1.98

193

Medical treatment for female infertility

205

0.92

0.09

1.0

232.14

284.73

ng/l

1.01

169

Malignant neoplasm of oral cavity, including Hilmo

145

0.90

0.09

1.0

291.88

328.03

ng/l

—

Herpesviral [herpes simplex] infections, including avohilmo

625

0.96

0.09

1.0

257.65

320.88

ng/l

2.45

458

Macular pucker

584

0.96

0.09

1.0

310.64

326.41

ng/l

0.24

396

Benign neoplasm: Skin of eyelid, including canthus

478

1.05

0.09

1.1

1.0

303.79

327.77

ng/l

0.27

334

Other diseases of arteries and capillaries

278

0.93

0.09

1.0

285.24

309.45

ng/l

0.20

186

Benign neoplasm of mouth and pharynx

321

1.06

0.09

1.1

1.0

214.38

311.19

ng/l

4.23

224

Viral infections characterized by skin and mucous membrane lesions

134

1306

1.03

0.09

1.1

1.0

262.97

315.54

ng/l

2.31

946

Other disorders of bone density and structure

1.11

0.09

1.2

1.0

383.00

268.84

ng/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.11

0.09

1.0

292.83

425.82

ng/l

—

Sulfasalazine

908

0.97

0.09

1.0

320.53

327.61

ng/l

0.08

663

Infective dermatitis

329

0.94

0.09

1.0

276.16

315.80

ng/l

0.44

236

Bacterial pneumonia, not elsewhere classified

130

1113

1.03

0.08

1.0

251.02

344.33

ng/l

6.19

104

789

Nail disorders

204

1.08

0.08

1.0

232.81

288.84

ng/l

0.80

143

Pre-eclampsia or eclampsia

451

0.95

0.08

1.0

1202.66

337.17

ng/l

0.54

340

Other bursopathies

400

0.95

0.08

1.0

346.69

334.87

ng/l

0.11

290

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

303

2393

0.98

0.08

1.0

285.37

338.79

ng/l

1.91

220

1754

Viral warts, including avohilmo

522

0.96

0.08

1.0

396.58

317.73

ng/l

1.00

379

Other hearing loss

849

0.97

0.08

1.0

326.23

331.81

ng/l

0.07

584

Other specific arthropathies, wide

0.83

0.08

1.0

255.80

303.93

ng/l

—

Muscle strain

0.83

0.08

1.0

224.40

282.16

ng/l

—

Systemic sclerosis

0.81

0.08

1.0

422.20

336.56

ng/l

—

Dermatographic urticaria

146

1.10

0.08

1.1

1.0

355.70

302.40

ng/l

—

101

Tuberculosis, IBD comorbidity

185

1.08

0.08

1.1

1.0

232.38

305.41

ng/l

1.13

117

Deep bite

188

1.07

0.08

1.0

312.14

295.43

ng/l

0.11

133

Viral warts

236

0.93

0.08

1.0

424.85

300.72

ng/l

0.96

165

Chronic nephritic syndrome

1.12

0.07

1.2

1.0

393.82

279.80

ng/l

0.64

Perforation of tympanic membrane

264

1.06

0.07

1.0

314.67

318.45

ng/l

0.03

182

Autoimmune diseases related-to ILD

289

2378

1.01

0.07

1.0

308.84

335.56

ng/l

0.61

208

1745

Coxarthrosis, primary

248

2027

1.02

0.07

1.0

350.27

348.75

ng/l

0.01

164

1454

Burns and corrosions

337

0.95

0.07

1.1

1.0

255.68

305.14

ng/l

0.56

243

Injuries involving multiple body regions

1.03

0.07

1.1

1.0

381.75

285.61

ng/l

—

Cyst of Bartholin Gland

0.83

0.07

1.3

1.0

282.29

334.97

ng/l

—

Atopic dermatitis

166

1297

1.02

0.07

1.0

281.10

336.57

ng/l

1.08

134

973

Unspecified kidney failure

306

0.95

0.07

1.0

251.50

316.39

ng/l

1.32

199

Atrial fibrillation and flutter

112

706

1.02

0.07

1.0

326.45

340.64

ng/l

0.18

546

Malignant neoplasm of endocrine gland

216

1.07

0.06

1.0

287.83

355.61

ng/l

0.80

148

Pleural plaque with presence of asbestos

224

0.94

0.06

1.0

240.13

330.13

ng/l

1.16

146

Glomerular disorders in diseases classified elsewhere

346

0.95

0.06

1.1

1.0

354.38

298.13

ng/l

0.84

246

Contact with and exposure to communicable diseases

470

1.04

0.06

1.1

1.0

222.94

303.82

ng/l

2.71

350

FESS (DNB20)

354

1.05

0.06

1.0

280.72

319.94

ng/l

0.72

258

Symptoms and signs involving the skin and subcutaneous tissue

248

2310

1.01

0.06

1.0

286.29

343.21

ng/l

2.05

192

1672

Duodenal ulcer

325

1.05

0.06

1.0

316.07

324.89

ng/l

0.10

210

Glaucoma-related operations

158

1.08

0.06

1.0

276.00

315.50

ng/l

0.55

100

Dislocation, sprain and strain of joints and ligaments of knee

189

1733

0.99

0.06

1.0

303.51

332.43

ng/l

0.43

143

1297

Gestational [pregnancy-induced] hypertension

415

0.96

0.06

1.1

1.0

323.47

337.41

ng/l

0.13

317

Otosclerosis

223

0.94

0.06

1.0

523.36

310.09

ng/l

1.35

149

Other disorders of cornea

286

1.05

0.06

1.0

320.88

318.27

ng/l

0.02

199

Paroxysmal tachycardia

574

1.03

0.05

1.0

268.42

348.43

ng/l

3.30

432

conjunctival haemorrhage

243

0.95

0.05

1.0

328.06

312.51

ng/l

0.12

161

Stenosis and insufficiency of lacrimal passages

247

1.05

0.05

1.1

1.0

301.92

325.60

ng/l

0.34

164

Dentofacial anomalies [including malocclusion]

208

1648

0.99

0.05

1.0

308.42

335.51

ng/l

0.48

150

1239

Septicaemia

148

1327

1.02

0.05

1.0

294.12

337.58

ng/l

1.26

103

930

Tuberculosis, wide

188

1.06

0.05

1.1

1.0

232.38

315.12

ng/l

1.34

120

Thrombocytopenia, unspecified

202

0.94

0.05

1.0

253.64

308.64

ng/l

0.51

133

Other disorders of conjunctiva

445

1.03

0.05

1.0

328.32

327.75

ng/l

0.01

305

Follow-up care involving plastic surgery

100

1.10

0.05

1.0

319.20

330.37

ng/l

—

Caries of enamel

341

2208

1.01

0.05

1.0

297.03

335.18

ng/l

1.05

253

1634

Primary coxarthrosis, bilateral

108

1060

1.02

0.05

1.0

312.99

333.16

ng/l

0.36

734

Cysts of oral region, not elsewhere classified

159

1.07

0.05

1.0

342.92

290.48

ng/l

0.49

105

Pre-eclampsia or poor fetal growth

523

0.97

0.05

1.0

1033.75

323.53

ng/l

0.56

395

Benign neoplasm: Parotid gland

242

0.95

0.05

1.1

1.0

313.24

304.04

ng/l

0.06

163

Lichen planus

426

1.03

0.05

1.1

1.0

350.77

336.36

ng/l

0.12

299

ILD medications: prednisolone, methylprednisolone, prednisone

372

2084

0.99

0.04

1.0

288.68

336.06

ng/l

1.53

279

1526

Ptosis of eyelid

363

0.96

0.04

1.1

1.0

196.85

328.38

ng/l

7.20

249

Other or unspecified ileus, impaction or obstruction

585

1.03

0.04

1.1

1.0

258.31

331.16

ng/l

2.62

411

Acute alcohol intoxication ICD-9

1.10

0.04

1.0

308.40

248.02

ng/l

—

Nontoxic multinodular goitre

596

1.02

0.04

1.0

317.68

352.12

ng/l

0.33

417

Triptan medication for migraine, min. 3 purchases

143

1054

1.01

0.04

1.0

258.45

348.41

ng/l

1.88

105

809

Acute upper respiratory infections

368

2188

1.01

0.04

1.1

1.0

297.53

346.26

ng/l

1.48

277

1583

Other embolism and thrombosis

388

1.03

0.04

1.1

1.0

329.07

309.66

ng/l

0.21

279

Ulcerative colitis (strict definition, require KELA)

388

1.03

0.04

1.0

289.32

309.47

ng/l

0.31

290

Vascular diseases of the intestine

119

0.92

0.04

1.0

216.83

309.26

ng/l

—

Glomerular diseases

527

1.02

0.04

1.1

1.0

332.44

318.53

ng/l

0.17

374

Tuberculosis, wide, including avohilmo

190

1.05

0.04

1.1

1.0

232.38

312.95

ng/l

1.29

122

Other local infections of skin and subcutaneous tissue

291

0.96

0.04

1.0

269.40

311.64

ng/l

0.76

203

Benign neoplasm of bone and articular cartilage

200

0.95

0.03

1.0

381.25

277.15

ng/l

0.45

134

Other diseases of blood and blood-forming organs

210

1.05

0.03

1.0

248.94

298.31

ng/l

0.38

137

Diabetic maculopathy

273

1.04

0.03

1.0

232.89

276.86

ng/l

0.85

207

Adverse effects, not elsewhere classified

462

0.97

0.03

1.0

317.53

323.80

ng/l

0.06

331

Urolithiasis

106

1075

0.99

0.03

1.0

311.03

312.95

ng/l

0.02

777

Emergency coronary revascularization (for ACS)

348

2086

1.01

0.03

1.0

295.15

340.16

ng/l

1.36

233

1547

LSIL lesion of the cervix uteri

161

1.06

0.03

1.0

291.17

317.72

ng/l

0.30

121

Methotrexate

411

0.97

0.03

1.0

422.74

338.14

ng/l

0.83

300

Infections with a predominantly sexual mode of transmission, including avohilmo

656

1.02

0.03

1.0

285.02

315.42

ng/l

0.69

486

Coronary revascularization (ANGIO or CABG)

322

1942

1.01

0.03

1.0

291.29

343.36

ng/l

1.62

221

1448

Obesity, other/unspecified

903

0.99

0.03

1.0

234.20

353.76

ng/l

2.19

676

Anomalies of dental arch relationship, including avohilmo

362

0.97

0.03

1.1

1.0

282.50

319.20

ng/l

0.49

270

Suppurative and unspecified otitis media

565

1.02

0.03

1.1

1.0

301.39

306.21

ng/l

0.06

411

Sequelae of injuries of lower limb

241

1.04

0.02

1.0

321.69

314.64

ng/l

0.06

168

Contact with other sharp object(s)

128

0.94

0.02

1.1

1.0

194.00

269.40

ng/l

1.35

Other and unspecified local infections of skin and subcutaneous tissue

269

0.97

0.02

1.0

269.40

312.90

ng/l

0.78

186

Excessive, frequent and irregular menstruation

487

0.99

0.02

1.0

360.57

372.82

ng/l

0.05

350

Familial hypercholesterolemia, with ischemic heart disease

309

0.97

0.02

1.0

253.82

316.84

ng/l

1.40

206

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

251

2196

0.99

0.02

1.0

292.33

346.72

ng/l

1.57

203

1561

Other diseases of stomach and duodenum

202

1.04

0.02

1.0

414.13

306.45

ng/l

0.68

128

Malignant neoplasm of thyroid gland, including Hilmo

222

1.04

0.02

1.0

292.35

350.66

ng/l

0.62

153

Inflammatory disease of uterus

242

1.03

0.02

1.0

362.89

338.31

ng/l

0.10

172

Hallux rigidus

489

0.98

0.02

1.0

391.14

332.68

ng/l

0.53

344

Percutaneous Coronary Intervention

321

1942

1.00

0.02

1.0

292.77

343.36

ng/l

1.54

217

1448

Other diseases of pancreas

292

1.03

0.02

1.0

248.62

316.53

ng/l

1.42

211

Suggestive for eosinophilic asthma

292

1.03

0.02

1.0

298.52

315.79

ng/l

0.17

207

Malignant neoplasm of oral cavity

117

0.94

0.02

1.0

303.33

330.87

ng/l

—

Unspecified jaundice

133

1.05

0.01

1.0

321.00

293.28

ng/l

—

Melanocytic naevi of other and unspecified parts of face

137

0.95

0.01

1.0

287.14

309.51

ng/l

—

Other disorders of patella

432

1.02

0.01

1.0

326.09

306.72

ng/l

0.22

330

Crohn's disease of small intestine

157

0.96

0.01

1.1

1.0

442.10

284.10

ng/l

—

109

Thyrotoxicosis

712

1.01

0.01

1.0

252.11

336.78

ng/l

2.13

513

Injuries to unspecified part of trunk, limb or body region

267

0.97

0.01

1.0

294.89

303.75

ng/l

0.09

185

Obesity due to excess calories

144

1431

1.01

0.01

1.0

239.82

335.25

ng/l

2.90

110

1062

Other specified/unspecified hearing loss

263

1.03

0.01

1.1

1.0

313.09

307.01

ng/l

0.04

179

Uterine polyps

484

0.99

0.01

1.0

295.54

374.09

ng/l

1.27

348

Other peripheral vertigo

283

1.02

0.01

1.0

371.83

317.67

ng/l

0.41

188

Spontaneous rupture of synovium and tendon

273

1.03

0.01

1.0

361.56

337.24

ng/l

0.15

197

Lesion of ulnar nerve

423

1.02

0.01

1.0

324.07

300.21

ng/l

0.16

306

Other disorders of eyelid

170

1596

1.00

0.01

1.0

294.16

368.98

ng/l

1.64

123

1127

Other epidermal thickening

116

0.95

0.00

1.1

1.0

201.17

298.68

ng/l

—

Hyperkalaemia

154

1.04

0.00

1.0

219.64

356.44

ng/l

2.32

Hernia of abdominal wall, postoperative

592

0.99

0.00

1.0

241.90

328.32

ng/l

2.55

483

Aplastic and other anaemias

163

1485

1.00

0.00

1.0

323.94

338.15

ng/l

0.27

127

1015

Embedded and impacted teeth

227

1.00

0.00

1.0

221.25

293.78

ng/l

1.68

162

Otitis media, unspecified

164

1.01

0.00

1.0

335.23

275.06

ng/l

0.45

110

Seborrhoeic keratosis

907

1.00

0.00

1.0

308.16

335.46

ng/l

0.45

648

Other coagulation defects

162

0.99

0.00

1.0

311.90

304.18

ng/l

—

111

Other inflammation of eyelid, including avohilmo

124

1237

1.00

0.00

1.1

1.0

286.28

341.24

ng/l

0.92

906

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

242

0.99

0.00

1.0

314.06

308.57

ng/l

0.04

160

Glomerulonephritis

272

0.99

0.00

1.1

1.0

314.33

303.96

ng/l

0.07

189

Other keratitis

288

1.01

0.00

1.0

320.86

326.62

ng/l

0.03

209

Macular hole

199

1.01

0.00

1.0

332.93

310.93

ng/l

0.18

127

Foreign body on external eye

415

0.99

0.00

1.0

358.44

286.23

ng/l

0.48

312

Thyrotoxicosis, other and/or unspecified

545

1.01

0.00

1.0

241.61

347.21

ng/l

2.36

397

Candidiasis

392

0.99

0.00

1.1

1.0

308.69

326.61

ng/l

0.26

272

Diabetic nephropathy

426

1.00

0.00

1.0

350.06

275.82

ng/l

1.10

302

Hypermetropia

170

1.00

0.00

1.2

1.0

328.08

304.96

ng/l

0.10

112

Inguinal or femoral hernia, bilateral

371

1.00

0.00

1.1

1.0

309.81

310.20

ng/l

0.00

260

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

206

1.02

0.00

1.0

289.50

307.35

ng/l

0.18

139

Benign neoplasm: Skin of other and unspecified parts of face

293

0.99

0.00

1.0

391.47

313.70

ng/l

0.38

202

Thyroiditis

168

1.01

0.00

1.0

249.42

316.87

ng/l

0.94

116

Ethmoidectomy

373

0.99

0.00

1.0

280.72

317.67

ng/l

0.67

273

Other and unspecified drugs and medicaments

231

1.00

0.00

1.0

313.47

301.25

ng/l

0.09

154

Mental and behavioural disorders due to tobacco

271

1.00

0.00

1.1

1.0

225.95

315.44

ng/l

2.70

193

Smoking dependency

271

1.00

0.00

1.1

1.0

225.95

316.43

ng/l

2.74

193

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

291

1.00

0.00

1.0

317.86

315.06

ng/l

0.02

198

Malignant neoplasm of endocrine gland, including Hilmo

246

1.02

0.00

1.0

283.58

347.65

ng/l

0.80

167

Unspecified lump in breast

401

1.00

0.00

1.0

288.21

362.88

ng/l

1.39

286

Inguinal hernia, bilateral

367

1.01

0.00

1.1

1.0

309.81

309.77

ng/l

0.00

257

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

355

2240

1.00

0.00

1.0

343.61

326.98

ng/l

0.25

245

1664

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

137

1.02

0.00

1.1

1.0

422.89

339.10

ng/l

—

102

Intestinal adhesions without obstruction

257

1.01

0.00

1.0

226.76

318.61

ng/l

1.76

179

Recurrent aphthous stomatitis , including avohilmo

383

0.99

0.00

1.0

294.50

323.98

ng/l

0.44

264

Use of peginterferon beta-1a

0.00

0.0

1.0

—

240.60

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.0

—

221.20

—

Malignant neoplasm of placenta, including Hilmo

0.00

-0.00

0.0

1.0

—

343.20

—

Brain astrocytoma

0.00

-0.00

0.0

1.0

—

293.25

—

Other surgical follow-up care

0.90

-0.00

1.0

188.50

312.32

ng/l

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.0

—

293.25

—

Superficial injuries involving multiple body regions

1.00

-0.00

1.0

255.00

294.17

ng/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

800

1.00

-0.00

1.0

323.91

337.67

ng/l

0.18

552

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.94

-0.00

1.0

231.33

264.00

ng/l

—

Autoimmune polyglandular failure

0.00

-0.00

0.0

1.0

—

349.60

—

Other specified/unspecified dorsopathies

0.99

-0.00

1.1

1.0

314.50

321.96

ng/l

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

313.40

—

Systemic sclerosis, icd10

0.86

-0.00

1.0

422.20

334.79

ng/l

—

Systemic sclerosis (FG)

0.85

-0.00

1.0

422.20

329.71

ng/l

—

Benign neoplasm of male genital organs

1.02

-0.00

1.2

1.0

351.67

283.22

ng/l

—

Other disorders of iris and ciliary body

0.91

-0.00

1.2

1.0

272.50

282.79

ng/l

—

Aggressive periodontitis

0.91

-0.00

1.2

1.0

232.50

287.39

ng/l

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

-0.00

0.0

1.0

—

367.20

—

Other complications of labour and delivery, not elsewhere classified

1.01

-0.00

1.0

201.40

281.79

ng/l

—

Ependymoma

0.00

-0.00

0.0

1.0

—

312.67

—

Benign neoplasm: Descending colon

250

1.00

-0.00

1.0

315.95

318.29

ng/l

0.02

172

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tau protein [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS